COMMON DRUGS
TABLE 10-6 Common Drugs
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Adrenergics |
|||
Alpha and beta agonists Epinephrine (Adrenalin)-SC or IM 0.1-1 mg in 1:1000 solution; IV-intracardiac 1:10,000 solution; ophthalmic 1:1000-1:50,000 solution |
Asystole, bronchospasm anaphylaxis, glaucoma |
Stimulates pacemaker cells; inhibits histamine and mediates bronchial relaxation; intraocular pressure decreased |
Ventricular arrhythmias, fear, anxiety, anginal pain, decreased renal blood flow, burning of eyes, headache |
Nursing implications: Use TB syringe for greater accuracy; massaging injection site hastens action; repeated injections may cause tissue necrosis; avoid injection in buttocks because bacteria in area may lead to gas gangrene; may make mucous plugs in lungs more difficult to dislodge.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Norepinephrine (Levophed)-IV 8-12 p-g/minutes titrated to desired response |
Acute hypotension, cardiogenic shock |
Increases rate and strength of heartbeat; increases vasoconstriction |
Palpitations, pallor, headache, hypertension, anxiety, insomnia, dilated pupils, nausea, vomiting, glycosuria, tissue sloughing |
Nursing implications: Observe vital signs, mentation, skin temperature, and color (earlobes, lips, nailbeds); tissue necrosis occurs with infiltration; antidote is phentolamine 5-10 mg in 10-15 mL normal saline.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Beta agonists Dobutamine (Dobutrex)-IV Acute heart failure 1.5-10 µg/kg/minutes |
Acute heart failure |
Stimulates cardiac contractile force (positive inotropy); fewer changes in heart rate than dopamine or isoproterenol |
Tachycardia, arrhythmias |
Nursing implications: Mix with 5% dextrose; do not dilute until ready to use; protect from light; administer with infusion pump; check vital signs constantly; extravasation can produce tissue necrosis; see Norepinephrine.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Dopamine (Inotropin)-IV 1-5 µg/kg/minutes titrated to desired response; gradually increase to 1-4 p-g/kg/minutes increments at 10-30 minutes intervals; must maintain at 20 µg/kg/minutes or less. |
Acute heart failure |
Cardiac contractility increased; Renal blood flow increased |
Ectopic beats, nausea, vomiting, tachycardia, anginal pain, dyspnea, hypotension |
Nursing implications: Monitor vital signs, urine output, and signs of peripheral ischemia; will cause tissue sloughing if infiltration occurs
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Isoproterenol (Isuprel)-10-15 mg sublingually; IV 0.5-5.0 µg/minutes in solution |
Cardiogenic shock, heart block, bronchospasm asthma, emphysema |
↑ Cardiac contractility; facilitates AV conduction and pacemaker automaticity |
Tachyarrhythmias, hypo ten sion, headache, flushing of skin, nausea, tremor, dizziness |
Nursing implications: Monitor vital signs, ECG; oral inhalation solutions must nor be injected.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Analgesics |
|||
Acetaminophen (Tylenol, Datril, Panadol)-PO 325-650 mg q4h |
Simple fever or pain |
Analgesic and antipyretic actions; no anti-inflammatory or anticoagulant effects |
No remarkable side effects when taken for a short period |
Nursing implications: Consult with physician if no relief after 4 days of therapy
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Aspirin (acetylsalicylic acid)-PO or rectal 0.3-0.6 g |
Minor aches and pains; fever from colds and influenza; rheumatoid arthritis; anticoagulant therapy |
Selectively depresses subcortical levels of CNS |
Erosive gastritis with bleeding, coryza, urticaria, nausea, vomiting, tinnitus, impaired hearing, and respiratory alkalosis |
Nursing implications: Administer with food or after meals; observe for nasal, oral, or subcutaneous bleeding; push fluids; check Hct, Hgb, prothrombin times frequently; avoid use in children with flu.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Butorphanol (Stadol) IM: 1-2 mg IV: 0.5-2 mg |
Obstetric use: Control pain, especially during labor. Avoid in opioid-addicted patients. |
30-40 times more potent than meperidine; onset: 2-15 minutes; duration: 0.5-2 hours |
No excessive sedation. Neonatal respiratory depression less than with meperidine. Sinusoidal FHR pattern after administration. |
Nursing implications: Care must be taken that drug is not given with meperidine, as it may potentiate effects of meperidine; avoid in opioid-addicted patients.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Codeine-PO, IM, or SC 15-60 mg (gr ¼ to 1) |
Control pain; may be used during the puerperium |
Nonsynthetic narcotic analgesic |
Of little use during labor; allergic response; constipation; GI upset |
Nursing implications: Note response to the medication; less respiratory depression; preferred for head injury patient.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Ecotrin (enteric-coated aspirin) |
See Aspirin |
See Aspirin |
See Aspirin |
Nursing implications: Note response to the medication; less respiratory depression; preferred for head injury patient.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Eiodolac (Lodine)-PO 400-1200 mg/day, 300-400 q6-8h |
Management of osteoarthritis; mild to moderate pain |
Inhibits prostaglandin synthesis; suppression of inflammation and pain (NSAID) |
Dyspepsia, asthma, drowsiness, rash, tinnitus, anaphylaxis |
Nursing implications: Give 30 minutes before or 2 hours after meals for rapid effect; may be taken with food to decrease GI irritation.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Fentanyl transdermal (Duragesic)-25-100 µg/hour |
Chronic pain; not recommended for postoperative pain Obstetric use: Short-acting pain control during labor. |
Binds to opiate receptors in the CNS to alter response and perception of pain |
Drowsiness, confusion, weakness, constipation, dry mouth, nausea, vomiting, anorexia, sweating |
Nursing implications: Apply to upper torso, flat, nonirritated surface; when applying, hold firmly with palm of hand 10-20 sec.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Hydrocodone/Acetaminophen (Vicodin)-PO 5-10 mg q4-6h |
Moderate to severe pain |
Bind to opiate receptors in Confusion, sedation, hypotenCNS; alter perception of and sion, constipation response to painful stimuli |
Confusion, sedation, hypotension, constipation |
Nursing implications: Assess: type, location, and intensity of pain before and 1 hour (peak) after giving; prolonged use may lead to physical and psychological dependence; give with food or milk to reduce GI irritation.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Hydromorphone (Dilaudid)-PO 2-4 mg q3-6h; IM 1-2 mg q3-6h up to 2-4 mg q4-6h; IV 0.5-1.0 mg q3h |
Moderate to severe pain; anti-tussive |
Bind to opiate receptors in the CNS; alter perception and response to pain |
Sedation, confusion, hypotension, constipation |
Nursing implications: Give PO with food or milk; give IV 2 mg over 3-5 minutes; fluids, bulk, and laxatives to minimize constipation.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Ibuprofen (Motrin)-300-800 mg oral 3-4/days not to exceed 3200 mg/day |
Nonsteroid anti-inflammatory, antirheumatic used in chronic arthritis pain |
Inhibition of prostaglandin synthesis or release |
GI upset, leukopenia; sodium/water retention |
Nursing implications: Give on empty stomach for best result; may mix with food if GI upset severe; teach caution when using other medications.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Indomethacin (Indocin)-PO 25 mg 3-4/days; increase to max 200 mg daily in divided doses |
Rheumatoid arthritis; bursitis; gouty arthritis |
Antipyretic/anti-inflammatory action; inhibits prostaglandin biosynthesis |
GI distress, bleeding; rash; headache; blood dyscrasias; corneal changes |
Nursing implications: Monitor GI side effects; administer after meals for best effect or with food, milk, or antacids if GI symptoms severe.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Ketorolac (toradol)-PO, IV 10 mg q4-6h; IM 30-60 mg initially, then 15-30 mg q6h; ophthalmic 1 gtt qid for 1 week |
Short-term management of pain; ocular itching due to allergies (NSAID) |
Inhibits prostaglandin synthesis producing peripherally mediated analgesia; antipyretic/ anti-inflammatory |
Drowsiness, dizziness, dyspnea, prolonged bleeding time, dyspepsia |
Nursing implications: May be given routinely or pm; advise dentist or MD before any procedure.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Meperidine HCI (Demerol)-PO or IM 50-100 mg q3-4h |
Pain due to trauma or surgery; allay apprehension before surgery |
Acts on CNS to produce analgesia, sedation, euphoria, and respiratory depression |
Palpitations, bradycardia, hypotension, nausea, vomitine, syncope, sweating, tremors, convulsions |
Nursing implications: Check respiratory rate and depth before giving drug; give IM, because subcutaneous administration is painful and can cause local irritation.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Obstetric use: maternal relaxation may either slow labor or speed up labor |
Depresses CNS, maternal and fetal; allays apprehension; PO peak action-1-2 hours; IM peak action first hour |
Maternal side effects same as above; also can depress fetus |
Nursing implications: Monitor maternal vital signs, contractions, progress of labor, and response to drug; fetal heart rate; if delivery occurs during peak action, prepare to give narcotic antagonist to mother or neonate or both.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Morphine SO₄-PO 10-30 mg (Roxanol, MS Contin); SC 8-15 mg; IV 4-10 mg; rectal 10-20 mg |
Control pain and relieve fear, apprehension, restlessness, as in pulmonary edema |
Depresses CNS reception of pain and ability to interpret stimuli; depresses respiratory center in medulla |
Nausea, vomiting, flushing, confusion, urticaria, depressed rate and depth of respirations, decreased blood pressure |
Nursing implications: Check rate and depth of respirations before administering drug; observe for gas pains and, smaller doses for aged; monitor vital signs; observe for postural hypotension.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Obstetric use: preeclampsia, eclampsia; uterine dysfunction; pain relief |
Increases cerebral blood flow; provides antihypertensive action; CNS depressant |
Respiratory and circulatory depression in mother and neonate; may depress contractions |
Nursing implications: Observe for level of sedation, respirations, arousability, and deep-tendon reflex; give narcotic antagonist as necessary; check I&O (urinary retention possible).
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Nalbuphine (Nubain) IV: 1 mg at 6-10 minutes intervals
|
Obstetric use: pain relief during labor. Avoid in opioid addicted patients. |
Onset: 2-15 minutes; duration: 1-4 hours |
Increased sedation and limited ceiling effect; ceiling effect for neonatal respiratory depression |
Nursing implications: Less nausea and vomiting and sedation if given with PCA. Prophylactic nalbuphine seems unable to prevent pruritis.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Naproxen (Naprosyn)-PO 250-500 mg bid
|
Mild to moderate pain; dysmenorrhea; rheumatoid arthritis; osteoarthritis (NSAID). |
Inhibits prostaglandin synthesis; suppression of inflammation |
Headache, drowsiness, dizziness, nausea, dyspepsia, constipation, bleeding |
Nursing implications: Take with a full glass of waler; avoid exposure to sun.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Oxycodone HO (Percodan, Tylox)-PO 3-20 mg; SC 5 mg
|
Postpartum use: control pain; may be used during puerperium; 5-6 times more potent than codeine |
Less potent and addicting than morphine; for moderate pain-episiotomy and “afterpains”; peak action 1 hour |
See Morphine SO₄ |
Nursing implications: Administer per order and observe for effect.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Pentazocine (Talwin)-PO 50-100 mg; IM 30-60 mg q3-4h
|
Relief of moderate to severe |
Narcotic antagonist, opioid antagonist properties, equivalent to codeine |
Respiratory depression, nausea, vomiting, dizziness, lightheadedness, seizures |
Nursing implications: Monitor respirations, BP; caution with patients with MI, head injuries, COPD.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antacids Antiadrenal |
|||
Aminoglutethimide (Cytadren)-250 mg q6h |
Cushing’s |
Inhibits enzymatic conversion of cholesterol to pregnenolone, thus reducing synthesis of adrenal glucocorticoids/ mineralocorticoids |
Cortical hypofunction, hypotension, hypothyroidism |
Nursing implications: Monitor: vital signs, lab values, disease signs and symptoms; observe frequently during periods of stress.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antianemics |
|||
Ferrous sulfate (Feosol, Fer-inSoD-adults, PO 300 rng-1.2 g qd; children under 6 years, PO 75-225 mg qd; 6-12 years, PO 120-600 mg qd |
Iron deficiency anemia; pro-phylactically during infancy, childhood, pregnancy |
Corrects nutritional iron deliciency anemia |
Nausea, vomiting, anorexia, constipation, diarrhea; yellow-brown discoloration of eyes, teeth |
Nursing implications: To minimize GI distress, give with meals; do nor give with antacids or tea; liquid form should be taken throug straw to prevent staining of teeth; causes dark-green/black stool.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antianginals |
|||
Atenolol (Tenormin)-PO 50-150 mg daily; IV 5 mg initially, wait 10 minutes, then another 5 mg |
Hypertension: angina; arrhythmias |
Blocks (cardiac) beta adrenergic receptors |
Fatigue, weakness, bradycardia, heart failure, pulmonary edema |
Nursing implications: Give 1 mg/minutes IV; check vital signs; assess for signs of fluid overload.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Isosorbide dinitrate (Isordil, Isorbid)-sublingual 2.5-10.0 mgq5-l0min for 3 doses; PO 5-10 mg initially, 10-40 mg q6h |
Acute angina: long-term pro-Produces vasodilation, dephylaxis for angina; heart creases preload failure |
Produces vasolidation, decreases preload |
Headache, dizziness, hypotension, tachycardia |
Nursing implications: Avoid eating, drinking, or smoking until sublingual tablets are dissolved; change positions slowly; aspirin or acetaminophen for headache.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Nitroglycerin-sublingual 0.25-0.6 mg prn; transdermal (patch) 2.5-15.0 mg/day; topical 2-3 inches q8h; IV 10-20 µg/minutes |
Angina pectoris; adjunctive treatment in Ml, heart failure, hypertension (IV form) |
Directly relaxes smooth muscle, dilating blood vessels; lowers peripheral vascular resistance; increases blood flow |
Faintness, throbbing headache, vomiting, flushing, hypotension, visual disturbances |
Nursing implications: Instruct patient to sit or lie down when taking drug, to reduce hypotensive effect; onset 1-3 minutes; may take 1-3 doses at 5 min intervals to relieve pain; up to 10/days may be allowed; if headache occurs, tell patient to expel tab as soon as pain relief occurs; keep drug at bedside or on person; watch expiration dates-tabs lose potency with exposure to air and humidity; alcohol ingestion soon after taking may produce shocklike syndrome from drop in BP; smoking causes vasoconstricting effect; causes burning under tongue; may crush between teeth to increase absorption.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antiarrhythmics |
Bretylium (Brelylol)-IV Ventricular fibrillation; ven0.5-10 mg/kg q6h; IM 5-10 tricular tachycardia mg/kg (max 250 mg in one site) |
Ventricular fibrillation; ventricular tachycardia |
Inhibits norepinephrine release from sympathetic nerve endings; increased fibrillation threshold |
Worsening of arrhythmia; tachycardia and increased BP initially; nausea, vominity; hypotension later |
Nursing implications: Monitor BP and cardiac status closely; rotate IM injection sites; no more than 5 mL/site.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Antiarrhythmics Diphenylhydantoin (Dilantin)-PO 100-200 mg 3-4 times daily; IV loading dose 10-15 mg/kg (not to exceed 50 mg/minutes), 50-100 mg over 5-10 minutes |
Digitalis toxicity; ventricular ectopy |
Depresses pacemaker activity in SA node and Purkinje tissue without slowing con-duction velocity |
Severe pain if administered in small vein; ataxia, vertigo, small vein; ataxia, vertigo, nystagmus, seizures, confusion, skin eruptions, hypotension if administered too fast |
Nursing implications: With IV use monitor vital signs; observe for CNS side effects; have 0, on hand; seizure precautions (padded side rails, nonmetal airway; suction, mouth gag); also see Anticonvulsants.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Lidocaine HCI-IV 50-100 mg; bolus; 1.-4 mg/kg/minutes, IV drip |
Ventricular taelovartlia; PVCs |
Depresses myocardial response to abnormally generated impulses |
Drowsiness, dizziness, nervousness, confusion. paresthesias |
Nursing implications: Monitor vital signs; observe for signs of CNS toxicity; monitor ECG for prolonged PR interval.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Procainamide HCI (PronestyI)-PO, IM 500-1000 mg 4-6 times qd: IV 1 g |
Atrial and ventricular arrhythmias; PVCs; overdose of digitalis; general anesthesia |
Depresses myocardium; lengthens conduction time between atria and ventricles |
Polyarthralgia, fever, chills, urticaria, nausea, vomiting, urticaria, nausea, vomiting, psychoses, rapid decrease in BP |
Nursing implications: Check pulse rate before giving; monitor heart action during IV administration.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Propranolol HCI (Inderal)-0.5-3.0 mg IV push (up to 3 mg); 20-60 mg orally 3-4 times daily |
Ventricular ectopy; angina unesponsive to nitrites, paroxysmal atrial tachycardia; hypertension |
Beta-adrenergic blocker, cardiac contractility decreased. Heart rate decreased. Myocardial oxygen requirement decreased |
Bradycardia, hypotension, vertigo, paresthesia of hands |
Nursing implications: Instruct patient to take pulse before each dose; do not give to patients with history of asthma or chronic obstructive pulmonary disease; no smoking, because hypertension may occur.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Quinidine SO₄-PO 0.2-0.6 g q2h loading dose: maintenance: 400-1000 mg tid-qid; IV 5-10 mg/kg over 30-60 minutes |
Atrial fibrillation; PAT; ventricular tachycardia; PVCs |
Lengthens conduction time in atria and ventricles; blocks vagal stimulation of heart |
Nausea, vomiting, diarrhea, vertigo, tremor, headache, abdominal cramps, AV block, cardiac arrest |
Nursing implications: Count pulse before giving; report changes in rate, quality, or rhythm; give drug with food; monitor BP daily.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antiasthmatics |
|||
Cromolyn sodium-inhale, 1 cap 4 times qd |
Perennial bronchial asthma (not acute asthma or status asthmaticus) |
Inhibits release of bronchocon, strictors-histamine and SRS-A; suppresses allergic response |
Cough. hoarseness. wheezing, dry mouth, bitter aftertaste, urticaria, urinary frequency |
Nursing implications: Instruct on use of inhaler-exhale; tilt head back; inhale rapidly, deeply, steadily; remove inhaler; exhale-repeat until dose is taken; gargle or drink water after treatment.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Anticholelithics |
|||
Ursodeoxycholic (Actigal) |
Gallstones |
Dissolves gallstones |
Diarrhea, avoid concurrent use with bile acid sequestrants with bile acid sequestrants |
Nursing implications: Monitor for pain, GI distress.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Anticholinergics (antimuscarinis) |
|||
Anticholinergics (antimuscarinis) Atropine, SO₄-0.3-1.2 mg PO, SC, IM, or IV; ophthalmic 0.5-1.0% up to 6 times qd |
Peptic ulcer; spasms of GI tract. Stokes-Adams syndrome; control excessive secretions during surgery |
Blocks parasympathomimetic effects of acetylcholine on effector organs |
Dry mouth, tachycardia, blurred vision, drowsiness, skin Bushing, urinary retention; contraindications: glaucoma and paralytic ileus |
Nursing implications: Observe for postural hypotension in ambulating patients; administer cautiously in aged; and monitor vital signs for pulse and respiratory rate changes.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
mg 3-4 x day |
Diverticulosis |
Antispasmodic |
Blurred vision, constipation. dry eyes, dry mouth |
Nursing implications: Report symptoms listed under side effects, abdominal pain.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
1-2 mg bid/tid; IM, IV 4.4 mcg/kg (preop); 100-200 mcg qid (ulcer) |
Inhibit salivation and respiratory secretions; peptic ulcer disease |
Inhibits action of acetylcholine (antimuscarinic action) |
Tachycardia, dry mouth, urinary hesitancy |
Nursing implications: Give 30.60 minutes. before meals; do not give within 1 hour of antacids; IM or IV may be given undiluted.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
0.125-0.5 mg 3-4 x day; or 0.375 mg twice a day in released tablets |
Diverticulosis |
Manages spasms of irritable bowel syndrome |
Constipation, dry mouth, blurred vision |
Nursing implications: Monitor for: pain, bleeding, constipation, drug reaction.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
(Banthine)-P0 15 mg qid; IM or IV 30 mg |
Decreases hypertonicity and hypersecretion of GI tract; ulcerative colitis; peptic ulcer |
Blocks neural transmission at ganglia of autonomic nervous system and at parasympathetic effector organs |
Nausea, gastric fullness, constipation, mydriasis |
Nursing implications: Give before meals; observe urinary output to avoid retention, particularly in elderly; mouth care to relieve dryness; contraindicated with glaucoma.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
0.3-0.6 mL tid |
bowel, biliary, and renal colic; prostatitis |
Blocks parasympathomimetic effects of acetylcholine |
Dry mouth, thirst, dilated pupils, skin flushing, elevated temperature, delirium |
Nursing implications:Administer 30-60 minutes before meals; observe for side effects; physostigmine salicylate is antidote.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Anticoagulants |
|||
Enoxaparin (Lovenox)-30-40mg bid SC, 7-10 days; or 1 mg/kg q12h |
Deep vein thrombosis; prophylaxis before knee and abdominal surgery |
Potentiates inhibitory effect of antithrombin |
Bleeding, anemia, thromhocytopenia |
Nursing implications: Observe injection sites for: hematomas, ecchymosis, or inflammation; ice cube massage at site prior to injection may lessen bruising.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Heparin-initial dose: IV 5,000-20,000-40,000 U followed by infusion over 24 hours |
Acute thromboembolic emergencies |
Prevents thrombin formation |
Hematuria, bleeding gums, ecchymosis |
Nursing implications: Observe clotting times-should be 20-30 minutes; antagonist is protamine sulfate.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Warfarin sodium (Coumadin)-initial dose: PO 10-15 mg; maintenance dose: PO 2-10 mg qd |
Venous thrombosis atrial fibrillation with embolixation; pulmonary emboli; myocardial infarction |
Depresses liver synthesis of prothromhin and factors VII, IX, and X |
Minor or major hemorrhage, alopecia, fever, nausea, diarrhea, dermatitis |
Nursing implications: Drug effects last 3-4 days; antagonist is vitamin K; avoid foods high in vitamin K; no aspirin.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Anticoagulant Antidotes |
|||
Protamine sulfate 1%-IV 10 mg/mL slowly; 1 mg/100 U heparin |
Overdose of heparin |
Positive electrostatic charge inactivates negatively charged heparin molecules |
Excessive coagulation; hypotension, bradycardia, dyspnea |
Nursing implications: Slow IV; no more than 50 mg in 10 minutes period; monitor VS continuously; check APTT for effectivenesss.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
(Konakion)-PO, IM, SC 2.5-25.0 mg; 0.5-1.0 mg in newborns |
Warfarin (Coumadin) hypoprothrombinemia; hemorrhagic disease in newborns |
Counteracts the inhibitory effects of oral anticoagulants on hepatic synthesis of vitamin K-dependent clotting factors |
Flushing, hypotension, allergic reactions; reappearance of clotting problems (high doses) |
Nursing implications: Give IV only if absolutely necessary; dilute with preservative-free 0.9% NaCI, D₅W, or D₅NaCI; protect solution from light; repeat injection may cause redness and pain; check PT for drug effect.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Anticonvulsants |
|||
Carbamazepine (Tegretol) 200 mg twice/day (range: 600-1200/day in divided doses) |
Multiple sclerosis |
Decreases synaptic transmis-sion in CNS by affecting sodium channels in neurons |
Contraindicated in hypersensitivity, bone marrow depres. sion; drowsiness, ataxia, agranulocytosis, aplastic anemia |
Nursing implications: Monitor: CBC, liver function, ECG. Therapeutic levels should be 6-12 mcg/mL; take medication as directed around the clock; use sunscreen due to photosensitivity.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Clonazepam (Klonopin)-PO 1.5 mg in 3 doses initially, 0.5-1.0 mg every third day |
Absence seizures (petit mal seizures, myoclonic seizures) |
Produces anticonvulsant and sedative effects in the CNS, mechanism unknown |
Drowsiness, ataxia, behavioral changes |
Nursing implications: Give with food; evaluate liver enzymes, CBC, and platelets; avoid abrupt withdrawal-may cause status epilepticus.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Diazepam (Valium)-PO 2-10 mg bid-qid; IM or IVE 5-10 mg |
All types of seizures |
Induces calming effect on limbic system, thalamus, and hypothalamus |
Drowsiness, ataxia, paradoxical increase in CNS excitability |
Nursing implications: IV may cause phlebitis; give IV injection slowly, because respiratory arrest can occur; inject IM deeply into tissue.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
500 mg/day, increase by 250 mg/day until effective |
Absence seizures |
Depresses motor cortex and reduces CNS sensitivity to convulsive nerve stimuli |
GI distress: nausea, vomiting, cramps, diarrhea, anorexia; blood dyscrasias |
Nursing implications: Administer with meals; regular CBC precautions to avoid injury from drowsiness.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Magnesium salts 4-5 g by IV infusion |
cirrhosis |
Osmotically active in GI tract |
Use caution in renal failure: contraindicated in: hypermagnesemia, anuria, heart block |
Nursing implications: Monitor vital signs, seizure precautions, I&O; respiratory rate must be 16 before administration.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Magnesium Sulfate-PO 1-3 g/IM or IVE 1-4 g loaing dose.followede bye continuous infusion |
Control seizures in pregnancy, epilepsy; relief of acute constipation; reduces edema, inflammation, and itching of skin; may inhibit preterm contractions |
Depresses CNS and smooth, cardiac, and skeletal muscle; promotes osmotic retention of fluid |
Flushing, sweating. extreme thirst, complete heart block. dehydration, depressed or absent reflexes, ↓ respirations |
Nursing implications: If given IV, monitor vital signs continuously; I&O; use with caution in patients with impaired renal function; observe mother and newborn for signs of toxicity if given near birth; antidote: calcium gluconate.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Phenytoin or diphenylhydantoin (Dilantin) SO₄-PO 30-100 mg 3-4 times qd; IV 150-250 mg |
Psychomotor epilepsy, convulsive seizures; ventricular arrhythmias |
Depresses motor cortex by preventing spread of abnormal electrical impulses |
Nervousness, ataxia, gastric distress, nystagmus, slurred tress, nystagmus, slurred speech, hallucinations, gingival hyperplasia |
Nursing implications: Give with meals or pc; frequent and diligent mouth care; advise patient that urine may turn pink to red-brown; midi patient signs of adverse reactions: mix IV with normal saline (precipitates with D₅W) Continued.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Primidone (Mysoline)-PO 100-250 mg, increase over 10 days not to exceed 2 g/day |
Tonic-clonic,focal, or local seizures |
Inhibits abnormal brain electrical activity; dose-dependent CNS depression |
Excessive sedation or ataxia, vertigo |
Nursing implications: Careful neurological, cardiovacular, respiratory assessment; have resuscitation equipment available.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Valproic acid (depakene)-PO 15 mg/kg/day, increase up to 60 mg/kg/day |
Absense, tonic-clonic, myoclonic, focal, or local seizures |
Inhibits spread of abnormal discharges through brain |
Nausea, vomiting, diarrhea (disappear over time); drowsiness or sedation if taken in combination with other anticonvulsants |
Nursing implications: Assess responses; monitor blood levels; precautions against excessive sedation; discourage alcohol use.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antidiarrheals |
|||
Antidiarrheals Diphenoxylate HCI with atroptne sulfate (Lomotil)-PO 5-10 mg tid-qid |
Diarrhea |
Increases intestinal tone and decreases propulsive peristalsis |
Rash, drowsiness, dizziness, depression, abdominal distention, headache, blurred vision, nausea |
Nursing implications: May potentiate action of barbiturates, opiates, and other depressants; closely observe patients receiving these drugs, and administer narcotic antagonists such as levallorphan tartrate (Lorfan), naloxone HCI (Narcan), and nalorphine HCI (Naline) as ordered; administer cautiously to patients with hepatic dysfunction-may precipitate hepatic coma.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Kaolin with pectin (Kaopectate)-adults, PO 60-120 mL after each bowel movement (BM); children over 12, PO 60 mL; 6-12 years, PO 30-60 mL; 3-6 years, PO 15-30 mL after each BM |
Diarrhea |
Reported to absorb irritants and soothe |
Granuloma of the stomach |
Nursing implications: Do not administer for more than 2 days, in presence of fever, or to children younger than 3 years.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Paregoric or camphorated opium tincture-5-10 mL q2h, not more than qid |
Diarrhea |
Acts directly on intestinal smooth muscle to increase tone and decrease propulsive peristalsis |
Occasional nausea; prolonged use may produce dependence |
Nursing implications: Contains approximately 1.6 mg morphine or 16 mg opium and is subject to federal narcotic regulations; admin-ister with partial glass of water to facilitate passage into stomach; observe number and consistency of stools-discontinue drug as soon as diarrhea is controlled; keep in tight light-resistant bottles.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antiemetics |
|||
Antiemetics Chlorpromazine (Thorazine-preop IM 12.5-25.0 g 1-2 hours before; IV 25-50 mg; PO 10-25 mg q4-6h; IM 25-50 mg q3-4h; suppository 50-100 mg q6-8h |
Nausea, vomiting, hiccup, preoperative sedation, psychoses |
Alters the effects of dopamine in the CNS; anticholinergic, alpha-adrenergic blocking |
Sedation, extrapyramidal reactions, dry eyes, blurred vision, hypotension, constipation, dry mouth, photosensitivity |
Nursing implications: Keep flat 30 minutes after IM; change positions slowly; frequent mouth care; may turn urine pink to red-brown.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Prochlorperazine dimaleate (Compazine)-5-30 mg qid PO, IM, rectal |
Nausea, vomiting, and retching |
See Trimethobenzamide HCI |
Drowsiness, orthostatic hypotension, palpitations, blurred vision, diplopia, headache |
Nursing implications: Use cautiously in children, pregnant women, and patients with liver disease.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Antiemetics Trimethobenzamide HCI (Tigan)-250 mg qid, PO, IM, rectal |
Nausea: vomiting |
Suppresses chemoreceptors in the trigger zone located in the medulla oblongata |
Drowsiness, vertigo; diarrhea, headache, hypotension; jaundice; blurred vision; rigid muscles |
Nursing implications: Give deep IM to prevent escape of solution; can cause edema, pain, and burning.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antifungal |
|||
Amphotericin B (Fungi-zone)-IV 5 mg/250 mL dextrose over 4-6 hours (to 1 mg/kg body weight) |
Severe fungal infections; histoplasmosis |
Fungistatic or fungicidal; binds to sterols in fungal cell membrane, altering cell permeability |
Febrile reactions; chills. nausea; vomiting; muscle/joint pain; renal damage; hypotension, tachycardia, arrhythmias; hypokalemia |
Nursing implications: Monitor for side effects; thrombophlebitis at IV site; BUN > 40; creatinine > 3; stop drug because of nephrotoxicity.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Ketoconazole (Nizoral)-oral 200-400 mg |
Histoplasmosis, systemic fungal infections |
Antifungal |
Headache, faitgue, dizziness; nausea, vomiting; decreased libido, impotence; gynecomastia, especially in men |
Nursing implications: Administer with food; avoid concomitant use of antacids, H₂ blockers; advise to report side effects .
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Nystatin (Nilstat, Myco-Nystatin)-PO, rectal, vaginal: 100,000-1,000,000 U 3-4 times qd |
Skin, mucous membrane infections (candila albicans); oral thrush, vaginits; intestinal candidiasis |
Fungaistatic and fungicidal; binds to sterols in fungal cell membrane |
Nausea, vomiting, GI distress diarrhea |
Nursing implications: Oral use-clear mouth of food; keep medication in mouth several minutes before swallowing; vaginal-usually requires 2 week therapy; continue use during menses; consult physician before using anti-infective douches: determine predisposing factors to infection (diabetes, pregnancy, antibiotics, tight-fitting nylon pantyhose).
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antigout |
|||
Antigout Allopurinol (Lopurin,Zyloprim)-P0 100 mg initially, 300 mg daily with meals |
Primary hyperuricemia, secondary hyperuricemia with cancer therapy |
Lowers plasma and urinary uric acid levels; no analgesic, anti-infammatory. or uricosuric actions |
Rash, itching; nausea, vomiting; anemia; drowsiness |
Nursing implications: Report side effects, particularly rash, because drug must be stopped; avoid driving or other complex tasks until drug effects known; give at least 3,000 mL fluid daily; minimum urine output of 2,000 mL/day; keep urine neutral or alkaline with sodium bicarbonate or potassium citrate; use cautiously with: liver disease, impaired renal function. history of peptic ulcers, lower GI disease, or bone marrow depression.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Colchicine-PO 1.0-1.2 mg acute phase; 0.5-2.0 mg nightly with milk or food; IV 1-2 mg initially |
Gouty arthritis, acute gout |
Inhibits leukocyte migration and phagocytosis in gouty joints; nonanalgesic, nonucricosuric |
Nausea, vomiting, diarrhea, abdominal pain, peripheral neuritis, bone marrow despression (sore throat, bleeding gums, sore mouth), tissue and nerve necrosis with IV use |
Nursing implications: Do not dilute IV form with normal saline or 5% dextrose-use sterile water to prevent precipitation; infuse over 3-5 minutes IV; potentiate drug action with alkaline ash foods (milk, most fruits and vegetables).
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Probenecid (Benemid)-PO 0.25-0.50 g twice daily pc |
Chronic gouty arthritis, no value in acute, adjuvant therapy with penicillin to increase plasma level. Relief of allergic symptoms |
Inhibits renal tubular resorption of uric acid; no analgesic or anti-inflammatory activity; competitively inhibits renal tubular secretion of penicillin and many weak organic acids |
Headache, nausea, vomiting. anorexia, sore gums, urinary frequency, flushing |
Nursing implications: Give with food, milk, or prescribed antacid; 3,000 mL/day fluids; avoid alcohol, which increases serum urates; do not take with aspirin-inhibits action of drug; renal function and hematology should be evaluated frequently; during acute gout, give with colchicine.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antihistamines |
|||
Astemizole (Hismanal)-PO 10 mg/day |
(rhinitis, urticaria); less sedating |
Block the effecrts of histamine |
Drowsiness, headache, fatigue, stimulation, dry mouth, rash, incread appetite (none of these are frequent) |
Nursing implications: Take 1 hour before or 2 hours after eating; good oral hygiene; may need to reduce calories.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Chlorpheniramine maleate (Chlor-Trimeton)-PO 2-4 mg tid-qid; SC, IM, or IV 10-20 mg |
Asthma; hay fever; serum reactions; anaphylaxis |
Inhibits action of histamine |
Nausea, gastritis, diarrhea, headache, dryness of mouth and nose, nervousness, irritability |
Nursing implications: IV may drop BP; five slowly; caution patient about drowsiness.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Diphenhydramine HCI (Benadryl)-PO 25-50 mg tid-qid; IM or IV 10-20 mg |
Allergic and pyrogenic reactions; motion sickness; radiation sickness; hay feverl Parkinson's disease |
Inhibits action of histamine on receptor cells; decreases action of acetylcholine |
Sedation, dizziness, inability to concentrate, headache, anorexia, dermatitis, nausea, diplopia, insomnia |
Nursing implications: Avoid use in newborn or preterm infants and patients with glaucoma; supervise abulationl caution against driving or operating mechanical devices; excitation or hallucinations may occur in children.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Nedocromil (Tilade) inhalation, 2 sprays |
Asthma |
Prevents the release of histamine frome sensitized mastcells |
Hypersensitivity, acute asthma attacks; does not relieve (may accelerate) bronchospasm |
Nursing implications: Monitor pulmonary function; use only as prescribed; if symptoms increase, notify health care professional; teach proper use of metered-dose inhaler.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Terfenadine (Seldane)-PO 60 mg 2 times daily |
Relief of allergic symptoms, nasal and dermatoses |
Blocks the effects of histamine |
Drowsiness, sedation, headache, nausea, adbdominal pain, dry mouth |
Nursing implications: Risk of arrhythmias if taking certain antibiotics; false-negative skin test reactions; take with food or milk.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antihyperglycemics |
|||
Aplha-glucosidase inhibitor Acarbose (Precose) 25 mg 3 x day; may be increased q4-8 weeks (range; 50-100 mg 3 X day) |
Diabete |
Alpha-glucosidase inhibitors/ oral hypoglycemic |
Overdose signs: flatulence, diarrhea, abdominal discomfort |
Nursing implications: Observe for side effects of hypoglycemia; take same time each day; do not double dose; therapy is long term.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Biguanide Metformin (Glucophage) 500 mg 2 x day; may increase by 500 mg to 2,000 mg/day |
Diabetes |
Decreases hepatic prodiction of glucose; decreases intestinal absoption of glucose |
Lactic acidosis; nausea, vomiting, diarrhea, abdominal bloating |
Nursing implications: Monitor glucose levels; take medication as directed; dietary compliance; metallic taste resolves spontaneously.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Sulfonylureas Acelohexamide (Dymelor)-PO 200-1,500 mg qd; 1-2/days; duration 12-24 hours |
Oral hypoglycemic; antidiabetic |
Lowers blood glucose by stimulating insulin release from beta cells; effective only of pancreas has ability to produce insulin |
Hypoglycemia(profuse sweating, hunger, headache, nausea, confusion, ataxia, coma), skins rashes, bone marrow depression, liver toxicity |
Nursing implications: Drug therapy must be combined with diet therapy, weight control, and planned, graded exercise; alcohol intolerance may occur (disulfiram reaction-flushing, pounding headache, sweating, nausea, vomiting); should not be taken at bedtime unless specifically ordered (nocturnal hypoglycemia more likely); take at same time each day; contraindicated in liver disease, renal disease, pregnancy.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Antilhyperglycemica Chlorpropamide (Diabinese)-PO 100-500 mg maintenance; not to exceed 750 mg/day; duration 30-60 hours |
See Acetohexamide |
See Acetohexamide |
See Acetohexamide |
Nursing implications:See Acetohexamide.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Glimepiride (Amaryl), glipizide (Glucotrol); 1-2 mg once daily; increase slowly up to 8 mg in one dose; 15 mg/day in divided dose |
Diabetes mellitus, adult onset |
Stimulate release of insulin from pancreas |
Photosensivitity, hypoglycemia; ingestion of alcohol may induce reaction |
Nursing implications: Observe for signs of hypoglycemia: long-term therapy; avoid aspirin, alcohol; follow prescribed diet/exercise program.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Glyburide (Micronase)-PO 2.5-5 mg initially; 1.25-20 mg/day |
See Acetohexamide |
See Acetohexamide |
See Acetohexamide |
Nursing implications:See Acetohexamide.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Tolazamide (Tolinase)-PO 100-500 mg; 1/day; duration 10-14 hours |
See Acetohexamide |
See Acetohexamide |
See Acetohexamide |
Nursing implications:See Acetohexamide.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Tolbutamide (Orinase)-PO 500-3000 mg; 2-3/days; duration 6-12 hours |
See Acetohexamide |
See Acetohexamide |
See Acetohexamide |
Nursing implications:See Acetohexamide.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Insulin-rapid acting Crystalline zinc (Regular) (Humulin R) (clear)-onset 0.5-1.0 hour; peak 2-4 hours; duration 6-8 hours |
Poorly controlled diabetes; trauma; surgery, coma |
Enhances trasmembrane passage of glucose into cells; promotes carbohydrate, fat, and protein metabolism |
Hypoglycemia (profuse sweating, nausea, hunger, headache, confusion, ataxia, coma) allergic reaction at injection site |
Nursing implications: Monitor blood and urine for glucose and acetone levels; insulin currently being used can be kept at room temperature for 1 mo; refrigerate stock insulin only; rotate injection sites; cold insulin leads to lipodystrophy, reduced absorption, and local reaction; only form of insulin that is given IV reaction; only form of insulin that is given IV.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Prompt insulin zinc suspension (Semilente) purified pork (cloudy)-onset 1-2 hours; peak 4-10 hourshr; duration 12-16 hours |
Patients allergic to Regular; used in combination with longer-lasting insulin |
See Crystalline zinc (Regular) |
See Crystalline zinc (Regular) |
Nursing implications: See Crystalline zinc (Regular); compatible with all Lente preparations.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Insulin-intermediate acting NPH insulin (isophane insulin suspension) purified pork (Humulin N⁺) (cloudy)-onset 1-2 hours; peak 5-12 hours; duration 18-24 hours |
Patients who can be controlled by one dose per day |
See Crystalline zinc (Regular) |
See Crystalline zinc (Regular) |
Nursing implications:Gently rotate vial between palms, invert several times to mix; do not shake; see Crystalline zinc (Regular).
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Antihyperglycemics Insulin zinc suspension (Lente insulin) (cloudy)-onset 1-3 hours; peak 6-12 hours; duration 18-24 hours |
Patients allergic to NPH |
See Crystalline zinc (Regular) |
See Crystalline zinc (Regular) |
Nursing implications: See Crystalline zinc (Regular).
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Insulin-slow acting Extended insulin zinc suspension (Ultralente, Humulin U) purified beef (cloudy)-onset 4-8 hours; peak 12-24 hours; |
Often mixed with Semilente for 24 hours curve |
See Crystalline zinc (Regular) |
See Crystalline zinc (Regular) |
Nursing implications: See Crystalline zinc (Regular).
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antihypertensives |
|||
Captopril (Capoten)-PO 50 mg tid |
Hypertension, heart failure |
Prevents production of angiotensin II; vasodilation |
Hypotension, loss of taste perception, proteinuria, rashes |
Nursing implications: Monitor VS and weight; take 1 hour before and 2 hours after meals; change positions slowly; avoid salt and salt substitutes.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Clonidine (Catapres)-PO 200-600 mcg/day; transdermal 100-300 mcg applied every 7 days |
Mild to moderate hypertension; also used for epidural pain management |
Stimulates alpha-adrenergic receptors in CNS |
Drowsiness; dry mouth; postural hypotension |
Nursing implications: Instruct patient to take same time each day; avoid sudden position changes; report: mental depression, swelling of feet, paleness or cold feeling in fingertips or toes, vivid dreams or nightmares.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Guanadrel (Hylorel)-PO 5 mg bid (range: 20-75 mg/d) |
Moderate to severe hypertension |
Prevents release of norepinephrine in response to sympathetic stimulation |
Confusion; fainting; fatigue; diarrhea; orthostatic hypotension; dizziness |
Nursing implications: Give with diuretics to minimize tolerance and fluid retention; weight twice weekly; less side effects after 8 weeks of therapy.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Guanfacine hydrochloride (Tenex)-PO 1 mg daily to maximum dose of 3 mg/day |
Hypertension combination with thiazide-like diuretics |
Centrally acting alphaadrenergic receptor agonist |
Drowsiness; weakness; dizziness; dry mouth; constipation; impotence |
Nursing implications: Warn patient not to drive or perform activities requiring alertness; take at bedtime to minimize sedation; monitor BP and pulse.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Guanethidine SO₄ (Ismelic)-PO 10-50 mg qd in divided doses |
Severe to moderately severe hypertension |
Blocks norepinephrine at post-ganglionic synapses |
Orthostatic hypotension, diarrhea, inhibition of ejaculation |
Nursing implications: Postural hypotension is marked in the morning and accentuated by hot weather, alcohol, and exercise; teach to rise slowly; with assistance.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Hydralazine HCI (Apresoline)-PO 10-50 mg qid |
Moderate hypertension |
Dilates peripheral blood vessels, increases renal blood flow |
Palpitations, tachycardia, angina pectoris, tremors, depression |
Nursing implications:.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
eclampsia |
Relaxes peripheral blood vessels (opens vascular bed-physiological dehydration) |
Headache, heart palpitations, gastric, irritation, coronary insufficiency, edema, chills, fever, sever depression |
Nursing implications: Side rails up; must not stand without assistance; may be given with diuretics; observe carefully; IM route only; monitor BP; IV for severe hypertension and preeclampsia; in pregnancy, must not decrease arterial pressure too much or too rapidly, otherwise will jeopardize uteroplacental perfusion.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Antihypertensives Methyldopa (Aldomet)-PO 500mg-2 g in divided doses |
Severe to moderately severe hypertension |
Inhibits formation of dopamine, a precursor of norepinephrine |
Initial drowsiness, depression with feelings of unreality, edema, jaundice, dry mouth |
Nursing implications: Contraindicated in acute and chronic liver disease; encourage not to drive car if drowsy.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Minoxidil (Loniten)-PO 5 mg/day (range: 10-40 mg/day) |
Severe hypertension, end-stage organ failure |
Relaxes vascular smooth muscle |
ECG changes; tachycardia; Na⁺, water retention, hypertrichosis |
Nursing implications: Depilatory cream may minimize increased hair growth; report resting pulse increase more than 20 beats/minutes; caution patient to change positions slowly.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Phentolamine hydrochloride (Regitine)-PO 50 mg 4-6 doses daily; IV, IM. or local 5-10 mg, diluted in minimum 10 mL normal saline |
Prevents dermal necrosis, hypertensive crisis; pheochromocytoma |
Blocks alpha-adrenergic receptors |
Weakness, dizziness, orthostatic hypotension, nausea, vomiting, abdominal pain |
Nursing implications: When giving parenterally, patient should be supine; monitor for overdosage (precipitous drop in BP); do not give with epinephrine.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Prazosin (Minipress)-PO 6-15 mg/d bid or tid |
Mild to moderate hypertension |
Dilates arteries and veins by blocking postsynaptic alpha₁-adrenergic recptors |
Dizziness, headache, weakness, palpitations; orthostatic hypotension with first dose |
Nursing implications: Monitor: I&O, VS, and weight at beginning of therapy; teach patient/family to check BP at least weekly; need to comply with other interventions (wt. reduction, diet, smoking cessation, exercise).
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Reserpine (serpasil)-PO 0.25 mg qd |
Mild to moderate hypertension |
Depletes catecholamines and decreases peripheral vasoconstriction, heart rate, and BP |
Depression, nasal stuffiness, increased gastric secretions, rash pruritus |
Nursing implications: Watch for signs of mental depression; closely monitor pulse rates of patients also receiving digitalis; avoid alcohol.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Obstetric use: Pre-eclampsia |
CNS=depressant tranquilizer; sedation is major effect; decreases neutral transmission to nerves; decreases tone in blood vessels |
Low level of toxicity; weight gain; diarrhea; allergic reactions-dry mouth, itching, skin eruptions |
Nursing implications: Side rails up; must not stand up without assistance; observe carefully; monitory BP.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Timolo (Timoptic)-PO 20-40 mg/day; ophthalmic 1 gtt 1-2 times/day |
Hypertension, migraine, glaucoma |
Blocks stimulation of myocardia l(beta₁) and pulmonary/vascular (beta₂) receptors |
Fatigue, weakness, depression, insomnia, peripheral vasoconstruction, diarrhea, nausea, vomiting |
Nursing implications: Check VS and evidence of heart failure; do not take if pulse < 50; avoid OTC cold remedies, cofee, tea, and cola.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Metaraminol (Aramine)-2-10 mg IM or 15-100 mg in 500 mL sodium |
Adrenalectomy |
Elevated systolic and diastolic BP by vasoconstriction |
Hypertension, cardiac arrhythmias; may cause hypertensive crisis, if on MAO inhibitors or anti depressants |
Nursing implications: Monitor VS frequently (q3-5min); observe for side effects; have phentolamine available as antidote.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Anti-infectives |
|||
Cefazolin (ancef, Kefzol)-IM or IV 250 mg-1.5g q6-12h |
Staphylococcus aureus; Escherichia coli; Klebsiella; group A and B Streptococcus; Pneumococcus |
Batericidal |
Allergic reaction: urticaria, rash; abnormal bleeding |
Nursing implications: See penicillin; may cause false-positive lab tests(Coombs, urine glucose); oral probenecid may be taken concurrently to prolong effects of drug.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Anti-infectives Cephalexin (Keflex)-PO 1-4 g daily in 2-4 equally divided doses |
Infections caused by gram-positive cocci; infections: respiratory, biliary, urinary, bone, septicemia, abdominal; surgical prophylaxis |
Bactericidal effects on suspectible organisms; inhibition of bacterial cell wall synthesis |
Nausea, vominting; urticaria; toxic paranoid reactions; dizziness; incread alkaline phosphatase; nephrotoxicity; bone marrow suppression |
Nursing implications: Peak blood levels delayed when given with food; report nausea, flushing, tachycardia, headache; monitor for nephrotoxicity and for bleeding.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Cephalothin (Keflin, Seffin)-IM, IV 2-12 g/day in 4-6 equally divided doses |
Same as cephalexin except not recommended for biliary tract infections |
Same as Cephalexin |
See Cephalexin |
Nursing implications: Same Cephalexin; pain at site of IM; given in large musclel; rotate sites.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Ciprofloxacin (Cipro)-PO 250-750 mg q12h; IV 200-400 mg q12h; ophthalmic 1-2 gtt q15-30min, then 4-6 times daily |
Lower respiratory tract infections; skin bone, and joint infections; UTI |
Inhibits bacterial DNA synthesis |
Restlessness, nausea, diarrehea, vomiting, abdominal pain |
Nursing implications: Give PO on an empty stomach unless GI irritation occurs, then take with food; do not take with milk or yogurt; IV over 60 minutes.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Clarithromycin (Biaxin)-7.5 mg/kg q12h; usual 500 mg q12h |
Peptic ulcer |
Inhibits protein synthesis of bacterial ribosome |
Hypersensitivity to other antibiotics; use with caution in liver/renal impairment |
Nursing implications: Take medication around the clock; report signs of superinfection, diarrhea; do not take during pregnancy.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Cloxacillin (Tegopen)-PO 250-500 mg q6h |
Penicillinase-producing staphylococci infections: respiratory, sinus, and skin |
Binds to bacterial cell wall, leading to cell death |
Nausea, vomiting, diarrhea, rashes, allergic reactions, seizures (high doses) |
Nursing implications: Give around the clock on an empty stomach; observe for signs of superinfection (black, furry tongue, vaginal itching, loose stools).
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Co-trimoxazole (bactrim, Septra)-PO 160 mg twice daily or 20 mg/kg/day for P.carinii pnuemonia |
acute otitis media; urinary tract infection; shigellosis; P. carinii pneumonia; prostatitis |
Bacteriostatic; anti-infective; antagonizes folic acid production; combination of sulfamethoxazole and trimethoprim |
Hypersensitivity; see Sulfisoxazole |
Nursing implications: IV administration can cause phlebitis and tissue damage with exteravasation.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Doxycycline (vibramycin)-PO 100 mg q12h on day 1 them 100 mg/day x 7 days; IV-200 mg in 1-2 inf. on day 1; then 100-200 mg/day |
chlamydia, other STDs lym disease |
Inhibits bacterial protein of the 30S bacterial ribosome |
Urticaria, diarrhea; nausea, vomiting; photosensitivity |
Nursing implications: Take prescribed medications as orderd; use sunscreen or protective clothing due to photosensitivity; report sings of superinfection, if original symptoms not improved.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Erythromycin-adults, PO 250 mg q6h; children, PO 30-50 mg/kg qd |
Pnuemonia; pelvic inflammatory disease; intestinal amebiasis; ocular infections; used if allergic to penicillin |
Inhibits protein synthesis of microorganism; more effective against gram-positive organisms |
Abdominal cramping, distention, diarrhea |
Nursing implications: Be sure culture and sensitivity done before treatment; give on empty stomach 1 hour before or 3 hours after meals; do not crush or chew tabs; do not give with fruit juice.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Anti-infectives Gentamicin (Garamycin)-IM, IV 3-5 mg/kg/day in 3-4 divided doses; topical; skin, eye |
Serious gram-negative infections; posssible S. aureus, uncomplicated urinary infections |
Bactericidal effects on susceptible gram-positive and gram-negative organisms and my-cobacteria |
Serious toxic effects: kidneys, ear; causes muscle weakness/paralysis |
Nursing implications: Monitor plasma levels (peak is 4-10 μg/mL); patients with burns, cystic fribrosis may need higher doses.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Metronidazole (Flagyl) 7.5 mg/kg q6h (not to exceed 4g/day) |
Diverticulosis |
Disrupts DNA and protein synthesis in suspecible organisms |
Cimetidine may decrease metabolism; seizures, dizziness, abdominal paini |
Nursing implications: Administer with food or milk to decrease GI symptoms; avoid alcohol; has unpleasant metallic tast; avoid OTC medication while on this drug.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Penicillin-penicillin G, penicillin G potassium, penicillin G procaine, ampicillin 400,00-1.2 mil U g8h x 10 days, or single dose of 2.4 mil U |
Streptococcus; staphylococcus; Pneumococcus; Gonococcus; Treponema pallidum |
Primarily bactericidal |
Dermatitis and delayed or immediate anaphylaxis |
Nursing implications: Outpatients should be observed for 20 minutes after injection; hospitalized patients should be observed at frequent intervals for 20 minutes after injection.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Pentamidine (Pentam)-IV 4 mg/kg once daily; inhale 300 mg via nebulizer |
Prevention or treament of P. carinii pneumonia |
Appears to disrupt DNA or RNA synthesis to protozoa |
Anxiety, headache, bronchospasm, cough, hypotension, arrhythmias, nephrotoxicity, hypoglycemia, leukopenia, thrombocytopenia, anemia, chills |
Nursing implications: assess for infection and respiratory status; unpleasant metallic taste may occur (not significant).
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Sulfisoxazole (Gantrisin), sulfamethizole (Thiosulfil), and sulfisomidine (Elkosin)-PO 2.4 g loading dose, then 1-2 g qid x 7-10 days |
Acute, chronic, and recurrent urinary tract infections |
Bacteriostatic and bactericidal |
Nausea, vomiting, oliguria, anuria, anemia, leukopenia, dizziness, jaundice, skin rashes, and photosensitivity |
Nursing implications: Maintenance of blood levels is important; encourage fluids to prevent crystal formation in kidnet tubules-push up to 3,000 mL/day; avoid in later stage of pregnancy and first month of life for newborn (may cause kernicterus).
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Tetracycline-doxycycline hyclate (Vibramycin), oxytetracycline (terramycin) tetracycline HCI (Sumycin)-PO 250-500 mg q6h; IM 250 mg/day; or IV 250-500 mg q8-12h |
Broad-spectrum antibiotic |
Primarily bateriostatic |
GI upsets such as diarrhea, nausea, vomiting; sore throat; black, hairt tounge; glossitis; inflammatory lesions in anogenital region |
Nursing implications: Phototoxic reactions have been reported; patients should be advised to stay out of direct sunlight; medication should not be given with milk or snacks, because food interferes with absorption of tetracyclines; do not give to pregnant women and children under 8 years.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
Trimethoprim (TMP)/sulfamethoxazole (SMZ) (Bactrim)-PO 160 mg TMP or 800 mg SMZ q12h for 14-21 days; IV 8-10 mg/kg TMP/40-50 mg/kg SMZ q6-12h |
Bronchitis, shigella enteritis, otitis media, P. carinii pneumonia, UTI, traveler's diarrhea |
Combination inhibits the metabolism of folic acid in bacteria; bactericidal |
Nausea, vomiting, rasher, phlebitis at IV site, aplastic anemia, hepatic cerosis |
Nursing implications: Check IV site frequently; do not give IM; give PO on empty stomach; take around the clock; avoid exposure to sun.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Anti-Inflamatory |
|||
|
Gastrointestinal Mesalamine (Asacol, Pentusa, Rowasa)-800 mg 3 X day for 6 weeks |
Local-acting antiinflammatory in GI tract |
Contraindicated if patient has allergy to sulfonamides or salicylates; acceleration of symptoms; abdominal pain |
|
nursing implications: Monitor for; abdominal pain, diarrhea, blood in stools, superinfection; if no improvement notify health care professional; may need diagnostic studies
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Olsalazine (Dipentum)-see mesalamine-PO 1 g/day in 2 divided doses |
See Mesalamine |
See Mesalamine |
See Mesalamine |
nursing implications: See Mesalamine
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Sulfasalazine (Azulifidine)-see mesalamine-PO 3-4 g/day in divided doses |
See Mesalamine |
See Mesalamine |
See Mesalamine |
nursing implications: See Mesalamine
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Glucocorticoids-inhalants Bedomethasone (Beclovent, Vanceril)-42-50 p.g/spray; 2 metered sprays 3-4 X day |
Emphysema |
Glucocorticoid (inhalation) |
Headache, hypersensitivity to fluorocarbon propellant; used with caution in diabetes or glaucoma |
nursing implications: Do not exceed 1 mg/day
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Plunisolide (AeroBid) 42-50 pg/spray; 2 metered sprays 2-4/days |
Emphysema |
Potent locally acting anti-inflammatory and immune modifier |
Headache, dysphonia, fungal infections; adrenal suppression with long-term use |
nursing implications: Monitor respiratory status and lung sounds; assess patients changing from systemic to inhaled glucocorticoids for 1
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Tïiaminolone (Azmacort)-See Bedomethasone |
Asthma |
See Bedomethasone |
See Bedomethasone |
nursing implications: See Bedomethasone
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Glucocorticoids-systemic Cortisone acetate-PO or IM 20-100 mg qd in single or divided doses |
ACTH insufficiency; rheumatoid arthritis; allergies; ulcerative colitis; nephrosis |
Anti-inflammatory effect of unknown action |
Moon facies, hirsutismm, thinning of skin, striae, hypertension, menstrual irregularities, delayed healing, psychoses |
nursing implications: Give oral form pc, with snack at bedtime; give deep IM (never deltoid); monitor vital signs; observe for behavior changes; skin care and activity to tolerance; diet-salt restricted, high protein, KC1 supplement; protect from injury
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Desoxycorticosterone acetate ( hydrocortisone)-IM/IV 100-500 mg q2-6h; PO 3-5 mg bid qid |
Addison s disease; burns; surgical shock; adrenal surgery |
Promotes reabsorption of sodium; restores plasma volume, BP, and electrolyte balance |
Edema, hypertension, pulmonary congestion, hypokalemia |
nursing implications: Salt restriction according to BP readings; monitor vital signs; weigh daily
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Dexamelhasone (Decadron)-PO 0.5-5.0 mg qd; IM or IV 4-20 mg qd |
Addison’s disease; allergic reactions; leukemia; Hodgkin's disease; iritis; dermatitis; rheumatoid arthritis |
Anti-inflammatory effect |
See Cortisone acetate |
nursing implications: Contraindicated in tuberculosis; see Cortisone acetate for nursing care
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
(Solu-Medrol)-IV, IM, 10-40 mg, slowly |
Glucocorticoid, corticosteroid |
See Dexamethasone |
See Dexamethasone |
nursing implications: See Dexamethasone
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Prednisolone (Deltsone)-5-60 mg/day single or divided dose |
Multiple sclerosis |
Suppress inflammation and normal immune response |
Depression, euphoria, peptic ulceration; thromboembolism |
nursing implications: Monitor for Homans' sign, abdominal pain, vomiting, tarry stools, mental status or mood changes
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Prednisone-PO 2.5-15.0 mg qd |
Rheumatoid arthritis; cancer therapy |
Anti-inflammatory effect of unknown action |
Insomnia and gastric distress |
nursing implications: See Cortisone acetate
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antilipemics |
|||
|
Cholestyramine (Questran)-PO 4 g 1-4 times/day |
Hypercholesterolemia; pruritus from increased bile |
Binds bile acids in GI tract, increased clearance of cholesterol |
Nausea, constipation, abdominal discomfort |
nursing implications: Take before meals; do not take with other medications; give others 1 hour before or 4-6 hours after
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Gemfibrozil (Lopid)-PO 1200 mg/day |
Hypercnoiesteroiemia |
May inhibit peripheral lipolysis and reduce triglyceride synthesis in liver |
GI upset (abdominal pain, epigastric pain, diarrhea, nausea, vomiting), rash, vision |
nursing implications: Usecaution when driving or doing tasks requiring alertness; take before meals
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Lovastatin (Mevacor)-PO 20-80 mg daily with evening meal |
Primary hypercholesterolemia |
Inhibits enzyme that catalyzes synthesis of cholesterol; decreases synthesis of LDL |
Headache, constipation, diarrhea, altered taste, blurred vision, muscle cramps |
nursing implications: Give with food; restrict fat, cholesterol, carbohydrates, and alcohol in diet
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Niacin (vitamin B„ nicotinic acid)-PO 1.5-6.0 g |
Hypercholesterolemia |
Decreases liver’s production of LDLs and synthesis of triglycerides |
GI upset, flushing, pruritus, hy- |
nursing implications: Take the drug with meals; prevent flushing by taking an aspirin 30 minutes before; monitor closely during first year of 1 therapy
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Simvastatin (Zocor)-10-20 mg qd |
See Lovastatin |
See Lovastatin |
See Lovastatin |
nursing implications: Give once in the evening with or without food
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antineoplastics |
|||
|
6 mercaptopurine (Purinethol)-PO 2.5 mg/kg/day; may increase to 5 mg/kg after 4 weeks; maintenance 1.5-2.5 mg/kg/day |
Leukemia (ulcerative) |
Antineoplastic |
Bone marrow depression, severe hepatotoxicity |
nursing implications: Monitor: bleeding, infection, liver function tests, skin care, nausea and vomiting
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Methotrexate (Rheumatrex) 15-30 mg/day for 5 days; repeat after 1 week for 3-5 courses |
Leukemia Breast, lung cancer |
Interferes with folic acid metabolism, resulting in inhibition of DNA synthesis and cell reproduction |
Pulmonary fibrosis, hepatotoxicity, stomatitis, signs and symptoms of chemotherapy side effects |
nursing implications: Monitor liver function; assess respiratory status; see nursing care of patients receiving chemotherapy
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Mitotane (Lysodren) 9-10 g/day in 3-4 divided doses initially; decrease for maintenance |
Adrenocortical carcinoma |
Affects pituitary disorders |
GI complaints; lethargy, somnolence |
nursing implications: Monitor: signs of disease progression, Gl abnormalities, abdominal pain
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antiparkinson Agents |
|||
|
Benztropine (Cogentin)-1-2 mg/day (range: 0.5-6 mg/day) |
Parkinson’s disease |
Blocks cholinergic activity in CNS |
Blurred vision, dry eyes; constipation; caution with antihistamines, phenothiazines |
nursing implications: Take as directed for best results; monitor for drowsiness, dizziness, orthostatic hypotension; good mouth care; use caution with OTC drugs, overheating (drug causes a decrease in perspiration)
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Carbidopà/levodopa (Sinemet)-10/100,25/100, 25/250 carbidopa/levodopa ratio |
Parkinson’s disease |
Levodopa is converted to dopamine in CNS, where it serves as a neurotransmitter |
Use with MAO inhibitors; may result in hypertensive crisis; some drugs can reverse effects, e.g., phenothiazines, reserpine |
nursing implications: Assess parkinsonian symptoms; monitor hepatic, renal function; teach about orthostatic hypotension, gastric ini-1 tation, drowsiness
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Biperiden (Akineton)-2 mg 3-4X/day; not to exceed 16 mg/day |
Parkinson’s disease |
Restores natural balance of neurotransmitters in CNS |
Same as Benztropine (Cogentin) |
nursing implications: See Benztropine
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Trihexyphenidyl (Artane)-1-2 mg daily; usual maintenance dose: 5-15 mg/day in divided dose |
Parkinson’s disease |
Inhibits action of acetylcholine |
|
nursing implications: Monitor symptoms; avoid orthostatic hypotension; mouth care
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antiplatelet |
|||
|
Clopidogrel (Plavix)-PO 75 mg qd |
Reduce risk of atherosclerotic event (Ml, stroke) |
Inhibits platelet aggregation |
Bleeding; neutropenia; reactions similar to aspirin |
nursing implications: Give once daily without regard to food; avoid aspirin, NSAlDs; observe for symptoms of: stroke, peripheral vas-1 cular disease, MI
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Dipyridamole (Persantine)-PO 70-100 mg 4 times/day; IV 570 p.g/kg |
Prevent thromboembolism; surgical graft patency; diagnostic agent in myocardial perfusion studies |
Decreases platelet aggregation; coronary vasodilator |
Headache, dizziness, hypotension, nausea; MI, arrhythmias with IV |
nursing implications: Take at evenly spaced intervals; avoid use of alcohol; if no GI irritation, take 1 hour before or 2 hours after meals
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Tidopidine (Tidid)-PO 250 |
Stroke prevention; prevent early restenosis of coronary stents |
Inhibits platelet aggregation; prolongs bleeding time |
Diarrhea, rashes, bleeding, intracerebral bleeding |
nursing implications: Give with food or immediately after eating
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antituberculous |
|||
|
First-line drugs Isoniazid-5-10 mg/kg up to 300 mg PO or IM |
Tuberculosis |
Supress or interferes with biosynthesis; bacteriostatic |
Peripheral neuritis, hepatitis, hypersensitivity |
nursing implications: Give pyridoxine (B₆) 10 mg as prophylaxis for neuritis; 50-100 mg as treatment
'Note: To minimize resistant strains, combination therapy is used long term.
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Ethambutol-15-25 mg/kg PO |
See Isoniazid |
See Isoniazid |
Optic neuritis (reversible with discontinuation of drug; very rare at 15 mg/kg); skin rash |
nursing implications: Use with caution with renal disease or when eye testing is not feasible; used in combination with other drug
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Rifamate combination (isoniazid with rifampin) Rifater combination (isoniazid and pyrazinamide with rifampin)-see Rifampin |
See Rifampin |
See Rifampin |
See Rifampin |
nursing implications: See Rifampin
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Rifampin-10-20 mg/kg PO mg IV |
tuberculosis, meningitis, H. influenzae |
Impairs RNA synthesis; bactericidal |
Hepatitis, febrile reaction, purpura (rare) |
nursing implication: Orange urine color; negates effect of birth control pills
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Streptomycin-15-20 mg/kg up to 1 g IM |
Tuberculosis, endocarditis, tularemia |
Inhibits protein synthesis; bactericidal |
Eighth cranial nerve damage, nephrotoxicity |
nursing implications: Use with caution in older patients or those with renal disease
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Pyrazinamide-15-30 mg/kg up to 3 g PO |
Tuberculosis |
Bactericidal |
Hyperuricemia, hepatotoxicity |
nursing implications: Loss of glycemic control in those with diabetes
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antiulcer |
|||
|
Aluminum hydroxide gel (Amphojel)-PO 5-10 mL q2-4h or 1 hour pc |
Gastric acidity; peptic ulcer; phosphatic urinary calculi; J. phosphorus level in chronic renal failure |
Buffers HCI in gastric juices without interfering with electrolyte balance |
Constipation and fecal im- |
nursing implications: Shake well before administering; encourage fluids to prevent impaction and milk-alkali syndrome
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Calcium carbonate (Titralac)-PO 1-2 g taken with H,O after meals and at bedtime |
Peptic ulcer and chronic |
Reduces hyperacidity |
Constipation or laxative effect |
nursing implications: See Aluminum hydroxide gel
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Cimetidine (Tagamet)-PO 300-600 mg q6h (qid); IM, IV 300 mg q6h |
Duodenal ulcers, GERD, gastric hypersecretion; peptic acid gastritis, heart burn; esophagitis |
Inhibits action of histamine at PL-receptor site, inhibits gastric acid secretion; neutralizes and absorbs excess acid |
Confusion, dizziness; nausea; rash; diarrhea, constipation; hypermagnesemia |
nursing implications: Give with meals or immediately after; avoid smoking; avoid prolonged administration to patients with renal insufficiency
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Cisapride (Propulsid)-5-10 mg 3-4X/day |
Peptic ulcer |
Enhances the release of acetylcholine at the myenteric plexus |
Anticholinergics will decrease effects; effects of alcohol accelerated |
nursing implications: Take as directed; do not miss dose even if feeling well; avoid mixing with OTC drugs; avoid alcohol (may cause drowsiness)
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Famotidine (Pepcid)-40 mg/day at bedtime or 20mg twice a day |
Peptic ulcer |
Inhibits gastric acid secretion by inhibiting histamine at H,-receptor site |
Use with caution: elderly, renal failure; confusion, arrhythmias, aranugloctosis, aspaltic anemia |
nursing implications: Assess for: epigastric pain, blood in stool or emesis; monitor lab values to avoid side effects; take medication for full course of treatment; avoid self medication with OTC drugs; avoid smoking
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Lansoprazole (Prevacid)-15 mg/day; with H. pylori: 30 mg twice a day with amoxicillin |
Peptic ulcer |
Binds to an enzyme in presence of gastric acid; prevents final transport of hydrogen ions into gastric lumen |
Hypersensitivity; use with caution in elderly; dose change needed with hepatic impairment |
nursing implications: Avoid alcohol; report signs ofi Gl bleeding, cramping, abdominal pain, vomiting
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Magnesium and aluminum hydroxides (Maalox suspension)-PO 5-30 mL ql-3h pc and hs |
Gastric hyperacidity; peptic ulcer; heartburn; reflux esophagitis |
Neutralizes and binds gastric acids, heals ulcers |
Constipation from aluminum hydroxide; diarrhea from magnesium hydroxide |
nursing implications: Encourage fluid intake; contraindicated for debilitated patients or those with renal insufficiency
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Misoprostol (Cytotec) 200 mcg 4 X day |
Peptic ulcer |
Prostaglandin analogue |
Hypersensitivity to prostaglandins; diarrhea; avoid during pregnancy |
nursing implications: Monitor effectiveness of the drug; report increase in abdominal pain, bleeding
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Nizatidine (Axid) see cimetidine |
See Cimetidine |
See Cimetidine |
See Cimetidine |
nursing implications: See Cimetidine
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Omeprazole (Prilosec) 20 mg once daily |
Peptic ulcer GERD |
Gastric acid-pump inhibitor |
Abdominal pain; contraindicated: hypersensitivity |
nursing implications: May cause drowsiness, dizziness. Avoid: alcohol, aspirin, NSAlDs, foods that cause GI irritation
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Ranitidine (Zantac)-PO 150mg bid; IM 50 mg q6-8h; IV 50 mg q6-8h |
Duodenal ulcer, gastric ulcer, GERD, gastric hyper secretion |
Inhibits action of histamine at H.-receptor site, inhibits gastric acid secretion |
Headache, malaise, nausea, constipation, diarrhea |
nursing implications: Food does not affect absorption; give 1 hour apart from antacids; smoking interferes with action
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Sucralfate (Carafate)-PO 1 g qid |
Prevention and treatment of duodenal ulcer |
Reacts with gastric acid to form a thick paste that adheres to the ulcer surface |
Constipation |
nursing implications: Give 1 hour before and at bedtime; do not crush or chew tablets; take antacids 30 minutes before or 1 hour after sucralfate; increase fluids and dietary bulk
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Antiviral |
|||
|
Acyclovir (Zovirax)-PO 200 mg, 3-5 times/day; IV 5 mg/kg q8h over 1 hour; topical 6 times daily for 1 week |
Herpes simplex (1,2) |
Converts to an active cytotoxic metabolite that inhibits viral DNA replication |
Headache, nausea, vomitin diarrhea, increased serum BUN and creatinine |
nursing implications: Measure I&O q8h; ensure adequate hydration; assess for common side effects; apply topical with finger cot or rubber glove; refer for counseling
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Indinavir (Crixivan)-PO 800 mg q8h |
HIV; possible prevention in combination therapy |
Inhibits action of HIV protease and cleavage of viral polyproteins |
Ketoacidosis; kidney stones; hyperglycemia; altered taste; acid regurgitation |
nursing implications: Give with water or other liquids (skim milk, coffee, tea, juice) 1 hour before or 2 hours after meal; avoid high-fat, highprotein meal within 2 hrs; with concurrent therapy, may need to take drugs 1 hour apart; capsules are sensitive to moisture-keep desiccant in bottle
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Nevirapine (Viramune)-PO200 mg qd for 2 weeks, then bid |
HIV; delays disease progression |
Binds to the enzyme reverse transcriptase; disrupts DNA synthesis |
Rash; Stevens-Johnson syndrome (severe erythema multiforme) |
nursing implications: Give with or without food; drug does not cure AIDS-decreases opportunistic infections
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Zidovudine (AZT, Retrovir)- PO 200 mg q4h |
AIDS and related disorders |
Inhibits HIV replication |
Blood disorders, especially anemia and granulocytopenia; headache; nausea; insomnia; myalgia |
nursing implications: Monitor for signs of opportunistic infection and adverse drug effects; drug must be taken around the clock; regular blood tests (q2wk)
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Blood Viscosity-Reducing Agent Pentoxifylline (Trental)-PO 400 mg tid |
Peripheral vascular disease (intermittent claudication) |
Increases flexibility of RBCs; inhibits platelet aggregation |
Nausea, vomiting, GI upset; drowsiness; dizziness; headache |
nursing implications: Give with meals to minimize GI irritation; take tablets whole; report persistent GI or CNS side effects
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Bronchodilators Albuterol (Ventolin)-PO 2-6 mg 3-4 times/day; inhale q4-6h or 2 puffs 15 minutes before exercise |
Bronchodilator |
Results in accumulation of cyclic adenosine monophosphate (cAMP) at betaadrenergic receptors |
Nervousness, restlessness, tremor, hypertension, nausea |
nursing implications: Give with meals; allow 1 minute between inhalations; rinse mouth with water after inhalation
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Aminophylline-PO 250 mg bid-qid: rectal 250-500 mg; IV 250-500 mg over 10-20 minutes |
Rapid relief of bronchospasm; asthma; pulmonary edema |
Relaxes smooth muscles and increases cardiac contractility; interferes with reabsorption of Na’ and Cl’ in proximal tubules |
Nausea, vomiting, cardiac arrhythmias, intestinal bleeding, insomnia, restlessness, and rectal irritation from suppository |
nursing implications: Give oral span class="font0" style="font-style:italic;">with or after meals; monitor vital signs for changes in BP and pulse; weigh daily; IM injections are painful
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Ephedrine SO₄-PO, SC, or IM 25 mg tid-qid |
Asthma: allergies; bradycardia; nasal decongestant |
Relaxes hypertonic muscles in bronchioles and GI tract |
Wakefulness, nervousness, dizziness, palpitations, hypertension |
nursing implications: Monitor vital signs; avoid giving dose near bedtime; check urine output in older adults
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Ipratropium (Atrovent) 1-4 inhalations |
Emphysema |
Inhibits cholinergic receptors in bronchial smooth muscle |
Nasal dryness, epistaxis; fluorocarbon toxicity when used with other inhalants |
nursing implications: Instruct proper use of inhaler; do not use more than 12 metered doses in 12 hours; if severe bronchospasm occurs, consult physician/nurse practitioner
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Isoproterenol HC1 (Isuprel)-inhalation of 1:100 or 1:200 solution |
Mild to moderately severe asthma attack; bronchitis; pulmonary emphysema |
Relaxes hypertonic bronchioles |
Nervousness, tachycardia, hypertension, insomnia |
nursing implications: Monitor vital signs before and after treatment; teach patient how to use nebulizer
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Bronchodilators Metaproterenol (Alupent) 20 mg 3-4 times/day; ininhalations |
Asthma |
Bronchodilation |
Nervousness, restlessness, tremor, paradoxical bronchospasm |
nursing implications: Assess lung sounds; observe for wheezing (paradoxical bronchospasm); observe patients’ respiratory signs and symptoms; refer to health care professional if symptoms persist or shortness of breath continues
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Salmeterol (Serevent)-50 pg twice a day (two inhalations) |
Asthma |
Produces accumulation of cAMP al beta-adrenergic receptors |
Headache, palpitations, abdominal pain; avoid when using beta-adrenergic agents (decreases effectiveness) |
nursing implications: Assess lung : i do not use for acute symptoms
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Theophylline-PO 400 mg/day in divided doses; max adult dose. 900 mg divided dose |
Treatment/prevention of em-Bronchodilation physema, asthma (bronchoconstriction); chronic bronchitis |
Bronchodilation |
Restlessness; increased respiration, heart rate; palpitations, arrhythmias; nausea, vomiting; increased urine output-> dehydration |
nursing implications: Monitor theophylline levels: 10-20 ug/mL monitor signs of toxicity; take with 8 oz water or with meals to decrease G1 symptoms
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Terbutaline (Brethine)-PO 2.5-5.0 mg q6h (not to exceed 20 mg/24 hours); SC 0,25 mg, repeat 15-30 minutes (not to exceed 0.5 mg/hour); inhalation-2 puffs (0.2 mg each) q4-6h |
Bronchospasm Obstetric use: may be used for premature labor; currently not FDA approved for use as tocolytic agent, but used |
See Isoproterenol |
See Isoproterenol If used in pregnancy: maternal and fetal tachycardia |
nursing implications: See Isoproterenol
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Zafirlukast (Accolate)-20 mg twice daily |
Asthma |
Antagonizes the effects of leukotrienes |
Headache, fever, infection, pain |
nursing implications: Monitor lung sounds, respiratory function
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Zileuton (Zyflo)-600mg qid |
Asthma |
Enzyme inhibitor |
Headache, fever, infection, chest pain increases blood level of theophylline, propranolol, warfarin |
nursing implications: Assess lung sounds; do not discontinue or reduce dosage without consulting health care professional; not used to treat acute attack
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Calcium Channel Blockers Amlodipine (Norvasc)-PO 5-10 mg qd |
Hypertension, angina pectoris, vasospastic angina (Prinzmetal’s), muscle cells |
Inhibits the transport of calcium into myocardial and vascular smooth muscle |
Arrhythmias, peripheral edema, heart failure, photosensitivity, gingival hyperplasia |
nursing implications: Instruct patient to: monitor pulse, report rate <50 beats/minutes, take with or without food
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Dilitiazem (Cardizem)-PO 30-120 mg 3-4 times/dat; IV 5-15 mg/hours |
Angina, hypertension, artial arrhythmias |
Inhiabits excitation-contraction; decreased SA, AV node conduction |
Headache, fatigue, arrhythmias, edema, hypotension, constipation, rash |
nursing implications: May take with meals; take pulse; do nor give drug if pulse <50 beats/minutes; change positions slowly; may take nitroglycerin sublingually concurrently
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Metoprolol (Lopressor)-100 mg/day up to 450 mg/day |
Hypertension |
Blocks stimulation of myocardial adrenergic receptors (beta,) |
Contraindictated in CFG, pulmonary edema; caution with renal impairment |
nursing implications: Monitor vitals, especially BP; prevent orthostatic hypotension; avoid self-medication with OTC; may cause drowsiness; medication may increase sensitivity to cold
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Nicardipine (Cardene)-PO 20-40 mg tid |
Angina, hypertension |
Calcium channel blocker, inhibits excitation-contraction |
Dizziness, light-headedness, headache, peripheral edema, flushing |
nursing implications: Give on an empty stomach; chest pain may occur 30 minutes after dose (temporary, from reflex tachycardia)
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Nifedipine (Procardia)-PO 10-30 mg tid (not to exceed 180 mg/day); sublingual 10 mg repeated in 15 minutes |
Angina, hypertension Obstetric use: may be used for premature labor. Currently not FDA approved for use as tocolytic agent |
Calcium channel blocker, vasodilation |
Dizziness, light-headedness, giddiness, headache, nervousness, nasal congestion, sore throat, dyspnea, cough, wheezing, nausea, flushing, warmth |
nursing implications: May take with meals; make position changes slowly; angina may occur 30 minutes after dose (temporary)
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Verapamil (Calan, Isopten)-PO 240-480 mg, 3-4 limes/day; IV 75-150 pg/kg |
Angina; supraventricular arrhythmias; essential hypertension |
Inhibits calcium movement into smooth-muscle cells; lowers pressure by reducing cardiac contractility |
Constipation, AV block, hepatotoxicity |
nursing implications:
Monitor VS and ECG for bradycardia and arrhythmias; observe for jaundice, abdominal pain; encourage fluids and bulk-forming foods| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Cardiac Glycosides |
|||
|
Digitoxin-digitalizing dose: PO 200 pg twice/day; IM or IV 200-400 pg; maintenance dose: PO 50-300 pg qd |
Heart failure: atrial fibrillation and flutter; supraventricular tachycardia |
Increases force of cardiac contractility, slows heart rate, decreases right atrial pressures, promotes diuresis |
Arrhythmias; nausea, vomiting; anorexia, malaise; color vision, yellow or blue |
nursing implications: Hold medication if pulse rate less than 50 or over 120; encourage foods high in potassium (e.g., bananas, orange juice); observe for signs of electrolyte depletion, apathy, disorientation, and anorexia
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Digoxin (Lanoxin)-digitalizing dose: PO 10-J 5 pg/kg; IV 0.6-1 mg/kg; maintenance dose: PO 0.125-0.375 mg qd |
See Digitoxin |
See Digitoxin |
See Digitoxin |
nursing implications: See Digitoxin
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Chemotherapy (see Tables 7-41 and Antineoplastica 10-8) |
|||
|
Cholinergic Bethanechol chloride (Urecholine)--PO 5-30 mg; SC 2.5-5.0mg |
Postoperative abdominal atony and distention; bladder atony with retention; postsurgical or postpartum urinary retention; myasthenia gravis |
Increases GI and bladder tone; decreases sphincter tone |
Belching, abdominal cramps, diarrhea, nausea, vomiting, incontinence, profuse sweating, salivation, respiratory depression |
nursing implications: Check respirations; have urinal or bedpan close at hand and answer calls quickly; atropine SO₄ is the antidote for cholinergic drugs
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Edrophonium (Tensilon)-IV 2 mg; IM 10 mg |
Diagnosis of myasthenia gravis; reversal of neuromuscular blockers |
Inhibits breakdown of acetylcholine; anticholinesterase, cholinergic |
Excess secretions, bronchospasm, bradycardia, abdominal cramps, vomiting, diarrhea, excess salivation, sweating |
nursing implications: Effects last up to 30 minutes; give IV undiluted with TB syringe
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Neostigmine (Prostigmin)-PO 15-30 mg q3-4h; SC, IM 0.25-1 mg |
Myasthenia gravis, postoperative bladder distention, urinary retention, reversal of neuromuscular blockers |
Inhibits breakdown of acetylcholine; cholinergic |
Excess secretions, bronchospasm, bradycardia, abdominal cramps, vomiting, diarrhea, excess salivation, sweating |
nursing implications: Take oral form with food or milk; with chewing difficulty, take 30 minutes before eating
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Pilocarpine HCI-1-2 gtts 1-2% solution up to 6 times/days |
Chronic open-angle and acute closed angle glaucome |
Contraction of the sphincter muscle of iris, resulting in miosis |
Brow ache, headache, occular pain, blurring and dimness of vision, allergic conjunctivitis, nausea, vomiting, profuse sweating; bronchoconstriction in patients with bronchial asthma |
nursing implications: Initially the medication may be irritating; te1 proper sterile technique for instilling drops-wipe excess solution to prevent systemic symptoms; discard cloudy solutions
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Physostigmine salicylate (Eserine)-0.1 mL of 0.25-10% solution: not more than qid; IM, IV 0.5-3 mg |
Glaucoma, reverse effects of tricyclic antidepressants, overdose, toxic effects of atropine and diazepam |
Increases concentration of acetylcholine |
Sweating, marked miosis, lacrimation, nausea, diarrhea |
nursing implications: If brown eyed, may require stronger solution or more frequent dose
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Pyridostigmine (Mestinon)-PO 60 mg/day X 3 days; IM, IV 2 mg q2-3h Maintenance: 60-150 mg/day |
Myasthenia gravis, reversal of neuromuscular blockers |
Inhibits breakdown of acetylcholine and prolongs its effects |
See Neostigmine |
nursing implications: See Neostigmine
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Central Nervous System Stimulants |
|||
|
Amphetamine SO₄-PO 5-60 mg qd in divided doses |
Mild depressive states; narcolepsy; postencephalitic parkinsonism; obesity control; minimal brain dysfunction in children (attention deficit disorder) |
Raises BP, decreases sense of fatigue, elevates mood |
Restlessness, dizziness, tremors, insomnia; increased libido; suicidal and homicidal tendencies; palpitations; anginal |
nursing implications: Give before 4 p.m. to avoid sleep disturbance; dependence on drug may develop; contraindicated with MAO inhibitors, hyperthyroidism, and psychotic states
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Methylphenidate hydrochloride (Ritalin)-PO 0.3 mg/kg/day or adults 20-60 mg in divided doses |
Childhood hyperactivity; narcolepsy; attention deficit disorder in children |
Mild CNS and respiratory stimulation |
Anorexia, dizziness, drowsiness, insomnia, nervousness, BP and pulse changes |
nursing implications: To avoid insomnia take last dose 4-5 hours beforea bedtime; vital signs; check weight 2-3 times weekly and report weight losses
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Decongestants Phenylephrine (NeoSynephrine, Sinex)-SC, IM 2-5 mg q!0-15min not to exceed 5 mg; IV 40-60 pg/minutes; nasal 2-3 gtts or 1-2 sprays q3-4h; ophthalmic 3 gtt/day |
Shock, hypotension, decongestant, adjunct to spinal anesthesia, mydriatic |
Constricts blood vessels by stimulating alpha-adrenergic receptors |
Dizziness restlesness, dyspnea, tachycardia, arrhythmias; ophthalmological: burning, photophobia, tearing |
nursing implications: Check for correct concentration; protect eyes from light sensitivity; blow nose before using; rebound congestion will occur with prolonged use
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Pseudoephedrine (Sudafed)-PO 60 mg q4~6h |
Nasal congestion, allergies, chronic ear infections |
Produces vasoconstriction in respiratory tract and possibly bronchodilation |
Nervousness, anxiety, palpitations, anorexia |
nursing implications: Give at least 2 hours before bedtime to minimize insomnia
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Diuretics Acetazolamide (Diamox)-PO 250-1000 mg/day; IV 500 mg |
Glaucoma; heart failure; convulsive disorders |
Weak diuretic; produces acidosis; self-limiting effect; increases bicarbonate excretion |
Electrolyte depletion symptomatalogy-lassitude, apathy, decreased urinary output, mental confusion |
nursing implications: Weigh daily; I&O; assess edema; give early in day to allow sleep at night; observe for side effects; replace electrolytes as ordered
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Ethacrynic acid (Edecrin)-PO 50-200 mg qd in divided |
Pulmonary edema; ascites; edema of heart failure |
Inhibits the reabsorption of Na' in the ascending loop of Henle |
Nausea, vomiting, diarrhea, hypokalemia, hypotension, gout, dehydration, deafness, metabolic acidosis |
nursing implications: Assess for dehydration-skin turgor, neck veins; hypotension; KCl supplement
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Furosemide (Lasix)-PO 40-80 mg qd in divided |
Edema and associated heart failure; cirrhosis; renal disease; nephrotic syndrome: hypertension |
Inhibits Na* and Cl* reabsorption in the loop of Henle |
Dermatitis, pruritis, paresthesia, blurring of vision, postural hypotension, nausea, vomiting, diarrhea, dehydration, electrolyte depletion, hearing loss (usually reversible) |
nursing implications: Assess for weakness, lethargy, leg cramps, anorexia; peak action in 1-2 hours; duration 6-8 hours; do not give at bedtime; supplemental KCl indicated; may induce digitalis toxicity
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Hydrochlorothiazide (HydroDlURIL and Esidrix 25-100 mg tid)-PO Diuril 0.5-1.0 qd |
Edema; heart failure; Na* retention in steroid therapy; hypertension |
Inhibits NaCI and water reabsorption in the distal ascending loop and the distal convoluted tubule of the kidneys |
Hypokalemia, nausea, vomiting, diarrhea, dizziness, paresthesias; may exacerbate diabetes |
nursing implications: Watch for and acetone
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Mannitol (Osmitrol)-50-100 gm/24 hours as 15-20% solution |
Cerebral edema, oliguria, acute renal failure, drug intoxication |
Hypertonic solution that kidney tubules cannot reabsorb. thereby causing obligatory water loss |
Diarrhea; water intoxication, thirst, headache |
nursing implications: Usually Foley catheter required; monitor cardiac and respiratory status; a rate of infusion to elicit 30-50 mL urine/hour
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Spironolactone (Aldactone)-PO 25 mg bid-qid |
Cirrhosis of liver; when other diuretics are ineffective |
Inhibits effects of aldosterone in distal tubules of kidney |
Headache, lethargy, diarrhea, ataxia, skin rash, gynecomastia |
nursing implications: Potassium-sparing drug; do not give supplemental KCl; monitor for signs of electrolyte imbalance
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Emetic Ipecac syrup-PO 15-30 mL for emesis, followed by 1-2 glasses H2O (adults and children > 1 year); 5-10 mL followed by 1/2-1 glass H20 (children < 1 year) |
Emergency emetic for poison ingestion |
NH, ions cause gastric irritatom |
Violent emesis, tachycardia, decreased BP, dyspnea |
nursing implications: Contraindicated in liver and renal disease; if given for emesis, follow dose with as much water as patient will drink
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Enzyme Pancrelipase (Viokase)-adults, PO 325 mg-1 g qd, during meals; children, PO 300-600 mg lid |
Chronic pancreatitis; cystic fibrosis; gastrectomy; pancreatectomy; sprue |
Assists in digestion of starch, protien, and fats; decreases nitrogen and fat content of stool |
Anorexia, nausea, vomiting, diarrhea, buccal/anal soreness (infants), sneezing, skin rashes, diabetes |
nursing implications: May be taken with antacid or cimetidine; do not crush or chew tabs; monitor I&O, weight; be alert for signs of di| abetes; children may use sprinkles
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Expectorats Guaifenesin (Robitussin)-100-400 mg q4h |
Respiratory congestion |
Increases expectoration by Low incidence of GI upset; causing irritation of gastric muscoa; reduce adhesiveness/surface tension of respiratory tract fluid |
Low incidence of GI upset; drowsiness |
nursing implications: Encourage to stop smoking; increase fluid intake; respiratory hygiene
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Terpin hydrate-PO 5-10 mL, q3-4h |
Bronchitis; emphysema> |
Liquefies bronchial secretions |
Nausea, vomiting, gastric irritation |
nursing implications: Give undiluted; push fluids
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Fibrinolytic Agents |
|||
|
Alteplase, recombinant (Activase, tPA)-IV bolus 100 mg given over 1-2 minutes; then 50 mg over 30 minutes; 35mg over 60min |
Acute MI; under investigation for pulmonary emboli, deep-vein thrombosis, and peripheral artery thrombosis |
Promotes conversion of plasminogen to plasmin, which is fibrinolytic |
Internal or local bleeding; urticaria; dysrhythmias related to reperfusion; hypotension; nausea, vomiting |
nursing implications: Assess for signs of reperfusion (relief of chest pain, no ST segment elevation); observe for bleeding; avoid IM in| jection; do not mix other medications in line
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Streptokinase-IV 1.5 million U diluted to 45 mL infused over 60 minutes |
Lysis of pulmonary or systemic emboli or thrombi; acute MI |
Reacts with plasminogen, dissolves fibrin clots |
Prolonged coagulation; allergic reactions; mild fever |
nursing implications: Monitor for signs of excessive bleeding, particularly at injection sites; avoid nonessential handling of patient
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Urokinase-IV 4400 lU/kg over 10min; 1.0-1.8 mL of 5000 lU/mL into catheter |
Massive pulmonary emboli, coronary artery thrombi, occluded IV catheter |
Directly activates plasminogen |
Bleeding, anaphylaxis, rash |
nursing-implications: Vital signs; check ql5min for bleeding during first hour; ql5-30min for 8 hours; have epinephrine ready
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Fibrinolytic Antidote |
|||
|
Aminocaproic acid (Amicar)-PO, IV 5 g loading dose; 1 g/hour to 30 g in 24 hours |
Management of streptokinase or urokinase overdose |
Inhibits plasminogen activator and atagonize plasmin |
Hypotension, bradycardia, cardiac arrhythmias |
nursing implications: Give slowly IV to prevent side effects; not recommended for D1C
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Hormones Chlorotrianisene (TACE), estrogen-PO 12-50 mg |
Prostatic cancer; menopause |
Nonsteroidal synthetic estrogen |
Rare after one course of treatment; thromboembolism; impotence and gynecomastia in men |
nursing implications: Supply patient with package insert; contraindicated in blood coagulation disorders
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Diethylstilbestrol (DES)-PO or IM 0.2-5.0 mg qd; vaginal suppository 0.1-0.5 mg at bedtime |
Prostate carcinoma; menopausal symptoms; osteoporosis; pain; mammary carcinoma; atrophic vaginitis |
Synthetic nonsteroidal compound with estrogenic effects on pituitary, ovaries, myometrium, endometrium, and other tissues |
Anorexia, nausea, vomiting. headache, diarrhea, dizziness, fainting-many side effects with long-term use |
nursing implications: Never give if `an is pregnant-predisposes to vaginal cancer in female offspring at puberty
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Estradiol-PO 1-2 mg for replacement therapy; up to 10 mg for cancer qd-tid; cyclic (on 3 weeks, off 1 week) |
Menopausal symptoms; osteoporosis; hypogenitalism; sexual infantilism; breast and prostatic carcinoma |
Inhibits release of pituitary gonadotropins; promotes growth of female genital tissues |
Anorexia, nausea, vomiting, diarrhea, fluid retention, mental depression, headache, thromboembolism; feminization in men |
nursing implications: Baseline VS; weigh daily; encourage frequent physical checkups to check serum lipids; teach breast seifexamination
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Medroxyprogesterone (Provera)-PO 2.5-10.0 mg; IM 400-1000 mg weekly |
Amenorrhea; functional uterine bleeding; threatened abortion; dysmenorrhea; adjunctive and palliative with renal cancer and endometriosis; PMS |
Similar to progesterone, but can be taken orally; thickens uterine decidua |
Drowsiness, cyclic menstrual withdrawal bleeding, GI upset, headache, edema, breast congestion |
nursing implications: Teach patient regarding self-administration; breast self-examination for possible breast changes
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Menotropins (Pergonal)-IM 1 amp (FSH + LH)/day for 9-12 days (followed by 5000-10,000 U HCG, if ovulation does not occur, repeat with 2 amp) |
Infertility use: treatment of secondary anovulation; stimulation of spermatogenesis |
Human gonadatropic responses; induces ovulation; sperm stimulation |
Abortions occur in 25%; failure rate 55-80% of patients; possible multiple births; ovarian enlargement; gynecomastia in men |
nursing lmpucations: Assist in collection of urine to assess estrogen levels; counsel regarding couple’s need to have daily intercourse from day of HCG injection until ovulation
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Progesterone-SC or IM 5-10 mg qd; sublingual 5-10 mg |
Amenorrhea; dysmenorrhea; endometriosis; habitual abortion |
Converts endometrium into secreting structure; prevents of mammary tissue |
Nausea, vomiting, dizziness, edema, headache, protein metabolism |
nursing implications: Give deep IM and rotate sites; weigh daily to ascertain fluid retention
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Testosterone-PO 5-10 mg qd; IM 25-50 mg 2-3 times/weeks; 200-400 mg IM q2-4wk for breast cancer |
Hypogonadism; eunuchism; impotence; advanced cancer of breast |
Growth of sex organs and appearance of secondary male sex characteristics; counteracts excessive amounts of estrogen |
Nausea, dyspepsia, masculinization, hypercalcemia, menstrual irregularities, renal calculi; Na+, K+, and H2O retention |
nursing implications: Observe for edema; weigh daily; I&O; push fluids for bedridden patients, to prevent renal calculi
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Vasopressin (Pitressin)-IM/SC 5-10 |x bid/qid; IM/SC 2.5-5 p. q2-3d for chronic therapy |
Diabetes insipidus |
Antidiuretic |
Nausea, flatus, tremor, pounding in head, water intoxication |
nursing implications: Monitor fluid balance, vital signs
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Immune Modifiers |
|||
|
Glatiramer acetate (Copaxone)-20 mg/day |
Multiple sclerosis |
Management of relapsingremitting MS |
Allergic reactions, anxiety, chest pain, weight gain, cough |
nursing implications: Monitor for side effects; new drug to attempt to control signs and symptoms of progressing multiple sclerosis
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Interferon p-lb (Betaseron)-30 p.g once a week |
Multiple sclerosis |
Reduce incidence of relapse |
Seizures, GI symptoms, flulike symptoms, neutropenia, injection site reactions |
nursing implications: Monitor progress of multiple sclerosis; determine if drug is effective in reducing incidence of relapse; provide information about multiple side effects
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Immunosuppressant Agents |
|||
|
Azathioprine (Imuran)-3-5 mg/kg/day initially; maintenance: 1-3 mg/kg/day |
Prevent renal transplant rejection Ulcerative colitis Rheumatoid arthritis |
Antagonizes purine metabolism/inhibition ofDNA/RNA synthesis |
Hypersensitivity; additive myelosuppression with antineoplasties; hepatotoxicity, leukopenia |
nursing implications: Assess for infection; monitor I&O and daily weight
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Cyclosporine (Sandimmune)-PO 5-10 mg/kg several hours before surgery; daily for 2 weeks; reduce dosage by 2.5 mg/kg/week to 5-10 mg/kg/day. IV 5-6 mg/kg several hours before surgery daily; switch to PO form as soon as possible |
Prevent organ rejection Ulcerative colitis Rheumatoid arthritis |
Inhibits interleukin-2, which is necessary for initiation of T-cell activity |
Hypersensitivity; caution with alcohol, renal impairment ` |
nursing implications: Monitor: l&O, daily weight, blood pressure; take as directed (time of day and with food); observe nephrotoxicity, gingival hyperplasia; avoid self administration of OTC drugs
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Muromonab-CD3 (Orthoclone OKT3)-IV 5 mg/day, 10-14 days |
Renal, liver, or cardiac transplant rejection |
Immunosuppression of T-cell function |
Tremor; dyspnea, shortness of breath; wheezing; chest pains; diarrhea; nausea, vomiting; chills, fever |
nursing implications: Draw solution into filter; give IV push over < 1 minute; do not give as IV infusion; do not mix with other medications
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Mycophenolate (CellCept)-PO 1 g bid |
Prevent renal transplant rejection |
Inhibits purine synthesis; sup-Diarrhea; vomiting; leukopenia; presses T and B lymphocytes |
Diarrhea; vomiting; leukopenmia; sepsis |
nursing implications: Give initial dose within 72 hour of transplant; give on empty stomach 1 hour before or 2 hours after meals; do not open, crush, or chew capsules; do not give with magnesium or aluminum antacids
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Tracrolimus-PO 0.075-0.15 mg/kg ql2h; IV 0.05-0.1 mg/kg/day |
Prevent rejection in liver transplant |
Inhibits T-lymphocyte activation |
Headache, insomnia, tremor, ascites, hypertension, peripheral edema, abdominal pain, rash, hyperglycemia, anemia |
nursing implications: Give 6 hours after transplant; oral therapy is preferred because of anaphylaxis with IV; therapy is lifelong
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Mineralocorticoid Agent |
|||
|
Fludrocortisone (Florinef)-PO 0.1-0.2 mg qd |
Addison’s |
Causes sodium reabsorption, hydrogen and potassium excretion, and water retention |
Heart failure; adrenal suppression, hypertension |
nursing implications: Do not miss dose; therapy is lifelong; high potassium; report: weight gain, muscle weakness, cramps, nausea, anorexia, dizziness
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Mucolytic Agent |
|||
|
Acetylcysteine (Mucomysl)-1-5 mL of 20% solution or 1-10 mL of 10% solution per nebulizer tid |
Emphysema; pneumonia; tracheostomy care; atelectasis; cystic fibrosis |
Lowers viscosity of respiratory secretions by opening disulfide linkages in mucus |
Stomatitis, nausea, rhinorrhea, bronchospasm |
nursing implications: Observe respiratory rate; maintain open airway with suctioning as necessary; observe asthmatics carefully for increased bronchospasm; discontinue treatment immediately if this occurs; odor disagreeable initially
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Muscle Relaxants |
|||
|
Baclofen (Lioresal)-5 mg tid up to 10-20 mg 4 times/day maintenance dose |
Relief of spasticity of multiple sclerosis, spinal cord injury |
Centrally acting skeletal-muscle relaxant; depresses polysynaptic afferent reflex activity at spinal cord level |
Pruritis, tinnitus; nausea, vomiting; diarrhea or constipation; drowsiness |
nursing implications: Administer with food if G1 symptoms; monitor for safety when ambulating; do not discontinue abruptly
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Dantrolene sodium (Dantrium)-25 mg/day to 25 mg bid-tid to 100 mg qid max |
See Baclofen |
See Baclofen |
See Baclofen |
nursing implications: See Baclofen
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Narcotic Antagonist |
|||
|
Naloxone HC1 (Narcan)-IV 0.1-0.2 mg repeated q2-3 minutes p.r.n up to 0.4-2 mg for narcotic-induced respiratory depression |
Reverses respiratory depression due to narcotics |
Reverses respiratory depression of morphine SO4, meperidine HC1, and methadone HC1; does not itself cause respiratory depression, sedation, or analgesia |
No common side effects; tachycardia, hypertension, nausea and vomiting with high |
nursing implications: Note time, type of narcotic, dosage received; not useful with CNS depression from other drugs; respiratory depression may return; monitor closely
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Sedatives and Hypnotics |
|||
|
Chlordiazepoxide HCI (Librium)-PO 5-10 mg; IM or IV 50-100 mg |
Psychoneuroses; preoperative apprehension; chronic alcoholism; anxiety |
CNS depressant resulting in mild sedation; appetite stimulant; anticonvulsant |
Ataxia, fatigue, blurred vision, diplopia, lethargy, nightmares, confusion |
nursing implications: Ensure anxiety relief by allowing patient to verbalize feelings; advise patient to avoid driving and alcoholic bever ages
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Chloral hydrate-PO 250 mg tid; hypnotic: PO 0.5-1.0 g; rectal supplement 0.3-0.9 g |
Sedation for elderly; delirium tremens; pruritus; mania; barbiturate and alcohol withdrawal |
Depresses sensorimotor areas of cerebral cortex |
Nausea, vomiting, gastritis; pinpoint pupils; delirium; rash; decreased BP, pulse, respirations, temperature; hepatic damage |
nursing implications: Caution: should not be taken in combination with alcohol; dependency is possible
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Diazepam (Valium)-PO 2-10 mg tid-qid; IM or IV 2-10 mgq3-4h |
Anxiety disorders; alcohol withdrawal; adjunctive therpreoperative or preprocedural sedation (also see Midazolam) |
Induces calming effect on limbic system, thalamus, and hypothalamus |
CNS depression-sedation or ataxia (dose related); dry mouth; blurred vision; mydriasis; constipation; urinary retenstion |
nursing implications: Do not mix with other drugs; IM injection painful; observe for phlebitis; monitor response; measures to ensure patient safety (e.g., falls); high potential for abuse; contraindicated in acute closed-angle glaucoma and porphyria
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Flurazepam (Dalmane)-PO > 15 years, 30 mg hs; elderly or debilitated, 15 mg hs |
Hypnotic |
Fastest acting; see Diazepam |
See Diazepam |
nursing implications: See Diazepam
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Hydroxyzine pamoate (Vistaril)-PO 25-100 mg qid |
See Chlordiazepoxide (Librium); antiemetic in postoperative conditions; adjunctive therapy |
CNS relaxant with sedative effect on limbic system and thalamus |
Drowsiness, headache, itching, dry mouth, tremor |
ursing implications: Give deep IM only; potentiates action of warfarin (Coumadin), narcotics, and barbiturates
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Lorazepam (Ativan)-PO 1-2 mg bid-tid (up to 10 mg); 2-4 mg hs; IM 4 mg max; IV 2 mg max |
Anxiety disorders; insomnia; alternative to diazepam for status epilepticus preanesthesia |
See Diazepam |
See Diazepam |
nursing implications: See Diazepam
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Meprobamate (Equanil, Miltown)-PO 400 mg tid-qid |
Anxiety; stress; absence seizures |
See Hydroxyzine pamoate (Vistaril) |
Voracious appetite, dryness of mouth, ataxia |
nursing implications: Older patients prone to drowsiness and hypotension; observe for jaundice
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Midazolam (Versed)-IM 0.05-0.08 mg/kg; IV 0.1-0.15 mg/kg |
Preanesthesia; prediagnostic procedures; induction of general anesthesia |
Penetrates blood-brain barrier to produce sedation and amnesia |
Respiratory depression, apnea, disorientalion, behavioral excitement |
nursing implications: Monitor ventilatory status and oxygenation; prevent injuries from CNS depression; nonirritating to vein
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Phenobarbital-sedative, PO 20-30 mg tid; hypnotic, PO 50-100 mg; IV or IM 100-300 mg; butabarbital (Butisol), pentobarbital (Nembutal), secobarbital (Seconal) |
Preoperative sedation; emergency control of convulsions; absence seizures |
Depresses CNS, promoting drowsiness |
Cough, hiccups, restlessness, pain, hangover; CNS and circulatory depression |
nursing implications: Observe for hypotension during IV administration; put up side rails on bed of older patients; observe for increased tolerance
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Promethazine (Phenergan)-IV, IM, PO 25-50 mg |
Preoperative sedation; postoperative sedation |
Antihistaminic; sedative, antiemetic, anti-motion sickness |
Drowsiness; coma; hypotension, hypertension; leukopenia; photosensitivity; irregular respirations; blurred vision; urinary retention; dry mouth, nose, throat |
nursing implications: Administer PO with food, milk; IM deep into large muscles, rotate sites; verify compatibility with other drugs; safety concerns due to sedative effect
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Serum |
|||
|
Immune globulin-IM 0.02 mL/kg |
Hepatitis |
Provides passive immunity |
Do not use if patient is hypersensitive |
nursing implications: Should be administered within 2 weeks of exposure
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Thyroid Hormone Inhibitors |
|||
|
Lugol's solution-PO 2-6 drops tid 10 days before thyroidectomy |
To reduce size, vascularity of thyroid before thyroidsurgery; emergency treatment of thyroid storm; or control of hyperthyroid symptoms after radioiodine (131I) therapy |
Inhibits thyroid hormone secretion, synthesis |
GI distress; stained teeth; increased respiratory secretions; rashes, acne |
nursing implications: Dilute in juice, give through straw; bloody diarrhea/vomiting indicates acute poisoning
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Propylthiouracil-PO 300-400 mg/day, divided initial dose; 100-150 mg/day maintenance dose; methimazole (Tapazole) 15-60 mg/day initial dose; 5-15 mg/day maintenance dose |
Hyperthyroidism; return patient to euthyroid state; also used preoperatively |
Inhibits functional thyriod hormone synthesis by blocking reactions; responsible for iodide conversion to iodine; inhibition of T4 conversion to T3 |
Blood dyscrasias, hepatotoxicity, hypothyroidism |
nursing implications: Teach importance of compliance with medication protocol; avoid iodine-rich foods (seafood, iodized salt); caution when using other drugs
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Saturated potassium iodide See Lugol’s solution (SSKI)-300 mg tid-qid |
See Lugol’s solution |
See Lugol’s solution |
See Lugol’s solution |
nursing implications: See Lugol’s solution
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Thyroid Hormone Replacement |
|||
|
Levothyroxine (Levothroid, Synthroid)-PO 0.05-0.10 mg/day; IV 200-500 p.g |
Hypothyroidism Myxedema coma |
Replacement therapy to alleviate symptoms Emergency replacement therapy |
Symptoms of hyperthyroidism |
nursing implications: Teach signs and symptoms of hyperthyroidism, hypothyroidism; monitor bowel activity; teach diet to combat constipation; keep medication in tight light-proof container, avoid foods that inhibit thyroid secretion (turnips, cabbage, carrots, peaches, peas, strawberries, spinach, radishes)
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Liothyronine (Cytomel)-PO 25 ug/day to maintenance dose 25-75 ug |
Mild hypothyroidism in adults |
Replacement therapy |
See Levothyroxine |
nursing implications:
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Uterine Contractants |
|||
|
Ergonovine maleate (Ergotrate)-PO, IM, IV 0.2 mg (gr 1/320) |
Postabortal or postpartum hemorrhage; promotes involution after delivery of placenta |
Stimulates uterine contractions for 3 hours or more |
Nausea, vomiting; occasional transient hypertension, especially if given IV; cramping |
nursing implications: Store in cool place; monitor maternal BP and pulse; do not use in labor
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Methylergonovine maleate (Methergine)-PO 0.2 mg; IM, IV, 0.2 mg (gr 1/320) |
Postpartum hemorrhage, after delivery of placenta |
Stimulates stronger and longer contractions than ergonovine maleate (Ergotrate) |
Nausea, vomiting, transient hypertension, dizziness, tachycardia; cramping |
nursing implications: Do not give if mother is hypertensive; do not use if solution is discolored; do not use in labor
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Oxytocin (Pitocin, Syntocinon) IM 0.3 1.0 mL; IV 1 mL (10 U) in 1000 mL solution |
Stimulates rhythmic contractions of uterus |
Induces labor; augments contractions; prevents or controls postpartum atony; antidiuretic effect |
Tetanic contractions, uterine rupture, cardiac arrhythmias FHR deceleration |
nursing implications: Contraindicated if cervix is unripe, in CPD, abruptio placentae, and cardiovascular disease; monitor: FHR, contractions, maternal BP, pulse, l&O; watch for signs of water intoxication with prolonged IV use; drug of choice in presence of hypertension; never use undiluted; DC if tetanic contractions occur; antidote: propranolol
| Drug and Dosage | Use | Action | Assessment:Side Effects |
|---|---|---|---|
|
Volume Expander |
|||
|
Albumin-IV 5%, 25% 500 mL as needed |
Cirrhosis |
Provides colloidal oncotic pressure, which mobilizes fluid from extracellular back into intravascular space |
Hypersensitivity, CHF, hepatic failure |
nursing implications: Monitor progress of disease; monitor for signs of shock; if fever, tachycardia, or hypotension occur, stop treatment and call physician